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Despite the development of antiviral drugs and the optimization of therapies,
the emergence of drug resistance remains one of the most challenging issues for suc-
cessful treatments of HIV-infected patients. The availability of massive HIV drug
resistance data provides us not only exciting opportunities for HIV research, but also
the curse of high dimensionality.
We provide several statistical learning methods in this thesis to analyze se-
quence data from different perspectives. We propose a hierarchical random graph
approach to identify possible covariation among residue-specific mutations. Viral
progression pathways were inferred using an EM-like algorithm in literature, and we
present a normalization method to improve the accuracy of parameter estimations.
To predict the drug resistance from genotypic data, we also build a novel regression
model utilizing the information from progression pathways. Finally, we introduce a
computational approach to determine viral fitness, for which our initial computational
results closely agree with experimental results.
Work on two other topics are presented in the Appendices. Latent class mod-
els find applications in several areas including social and biological sciences. Finding
explicit maximum likelihood estimation has been elusive. We present a positive so-
lution to a conjecture on a special latent class model proposed by Bernd Sturmfels
from UC Berkeley.
Monomial ideals provide ubiquitous links between combinatorics and commu-
tative algebra. Irreducible decomposition of monomial ideals is a basic computational
problem and it finds applications in several areas. We present two algorithms for find-
ing irreducible decomposition of monomial ideals.
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Many diseases spread from animals to humans. Recent examples include avian
influenza (bird flu) and severe acute respiratory syndrome (SARS), which was tracked
to civet cats. The human immunodeficiency virus (HIV), which crossed from primates
into humans, is the most deadly pathogen so far.
Acquired immunodeficiency syndrome (AIDS) is caused by HIV, the first cases
of the current epidemic probably occurred in the 1930s, and the disease spread rapidly
in the 1970s. It was first publicly reported in the United States in 1981 and has since
become a major worldwide epidemic [6]. It is estimated that 1.3 million persons in the
United States are currently living with HIV infection, and more than 550,000 of them
have already died [52]. Globally 40 million people are infected, the vast majority in
developing countries, and numbers continue to rise. Today AIDS is the major killer
of young adults.
This chapter aims to provide some background information of HIV biology.
Many material and facts are cited from publicly available sources, such as Wikipedia
[6] and AIDSinfo [3]. Also our presentation is far from complete. For example the
following topics are not covered: the transmission/prevension of HIV, viral dynamics,
1
therapy optimization and HIV vaccine. We focus on self-contain material relevant for
drug resistance, which serves for latter chapters.
1.1 Viral replication cycle
There are two main sub-types of virus: HIV-1 and HIV-2, the former being
prevailing and the latter being harder to transmit and slower-acting. In this thesis
the object of our study is HIV-1.
HIV is genetic material covered with a coat of protein molecules. It has fewer
than 10 genes. It has ribonucleic acid (RNA) as its genetic material that contains the
instructions specifying the biological development of cellular life. HIV also belongs
to the family of viruses known as lentiviruses (a member of the retrovirus family),
which means slow-acting.
Viruses are parasitic, and can only replicate by entering host cells. HIV pri-
marily infects vital cells in the human immune system such as helper T cells (specifi-
cally CD4+ T cells), macrophages, and dendritic cells. Within these cells, it produces
more virus particles by converting viral RNA into DNA in the cell and then making
many RNA copies. HIV replication cycle consists of the following main steps [3]. A
visualization of the cycle can be seen in Figure 1.1.
Binding and Fusion: HIV begins its life cycle when it binds to a CD4+
receptor and one of two co-receptors on the surface of a CD4+ T-lymphocyte. The
virus then fuses with the host cell. After fusion, the HIV RNA and various enzymes,
including reverse transcriptase, integrase, ribonuclease and protease, are injected into
the cell.
Reverse Transcription: An HIV enzyme called reverse transcriptase
(RT) converts the single-stranded HIV RNA to double-stranded HIV DNA. The con-
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Figure 1.1: The HIV replication cycle [6].
version from RNA to DNA is done through reverse transcriptase. The switch from
RNA to DNA and back to RNA is significant and makes combating HIV difficult.
Each time it occurs there is a possibility of errors and the virus mutating. This is
made more likely because reverse transcriptase lacks the normal proofreading that
occurs with DNA replication.
Integration: The newly formed HIV DNA enters the host cell’s nucleus,
where an HIV enzyme called integrase ”hides” the HIV DNA within the host cell’s
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own DNA. The integrated HIV DNA is called provirus. The provirus may remain
inactive for several years, producing few or no new copies of HIV.
Transcription: When the host cell receives a signal to become active, the
provirus uses a host enzyme called RNA polymerase to create copies of the HIV
genomic material, as well as shorter strands of RNA called messenger RNA (mRNA).
The mRNA is used as a blueprint to make long chains of HIV proteins.
Assembly: An HIV enzyme called protease (PR) cuts the long chains of HIV
proteins into smaller individual proteins. As the smaller HIV proteins come together
with copies of HIV’s RNA genetic material, a new virus particle is assembled.
Budding: The newly assembled virus pushes out (”buds”) from the host cell.
During budding, the new virus steals part of the cell’s outer envelope. This envelope,
which acts as a covering, is studded with protein/sugar combinations called HIV
glycoproteins. These HIV glycoproteins are necessary for the virus to bind CD4+ and
co-receptors. The new copies of HIV particles break out of the cell, destroying it and
can now move on to infect other cells.
HIV infection leads to low levels of CD4+ T cells through three main mecha-
nisms: firstly, direct viral killing of infected cells; secondly, increased rates of apoptosis
in infected cells; and thirdly, killing of infected CD4+ T cells by CD8 cytotoxic lym-
phocytes that recognize infected cells. When CD4+ T cell numbers decline below
a critical level, cell-mediated immunity is lost, and the body becomes progressively
more susceptible to opportunistic infections.
1.2 Anti-viral drugs and drug resistance
After nearly 30 years, HIV infection remains a significant cause of morbidity
and mortality. Major advances in HIV treatment have revolutionized patient care and
4
Table 1.1: FDA Approved Antiretroviral drugs.
Generic Name Brand & Other Names FDA Approval Date
Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Delavirdine Rescriptor, DLV April 4, 1997
Efavirenz Sustiva, EFV Sept. 17, 1998
Etravirine Intelence, Celsentri, Jan. 18, 2008
Nevirapine TMC125, ETR June 21, 1996
Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Abacavir Ziagen, ABC Dec. 17, 1998
Didanosine Videx, ddI, Videx EC Oct. 9, 1991
Emtricitabine Emtriva, FTC, Coviracil July 2, 2003
Lamivudine Epivir, 3TC Nov. 17, 1995
Stavudine Zerit, d4T June 24, 1994
Tenofovir DFViread, TDF Oct. 26, 2001
Zidovudine Retrovir, AZT, ZDV March 19, 1987
Protease Inhibitors (PIs)
Amprenavir Agenerase, APV April 15, 1999
Atazanavir Reyataz, ATV June 20, 2003
Darunavir Prezista, TMC114, DRV June 23, 2006
Fosamprenavir Lexiva, FPV Oct. 20, 2003
Indinavir Crixivan, IDV March 13, 1996
Lopinavir, Ritonavir Kaletra, LPV/r Sept. 15, 2000
Nelfinavir Viracept, NFV March 14, 1997
Ritonavir Norvir, RTV March 1, 1996
Saquinavir Invirase, SQV Dec. 6, 1995
Tipranavir Aptivus, TPV June 22, 2005
Entry/Fusion Inhibitors
Enfuvirtide Fuzeon, T-20 Hoffmann-La March 13, 2003
Maraviroc Selzentry, MVC Aug. 6, 2007
Integrase Inhibitors
Raltegravir Isentress Oct. 12, 2007
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prolonged survival, with the result that HIV infection can now be effectively managed
as a chronic disease.
1.2.1 Antiretroviral drugs and drug resistance
Anti-viral drugs are ’smart’ drugs that target at certain step of viral replica-
tion cycle to make an obstacle to its replication. The first drug, AZT (zidovudine),
became available in 1987 but effective treatment was achieved in 1996/7 with the
advent of highly active antiretroviral therapy (HAART), initially based on two nu-
cleoside reverse transcriptase inhibitors (NRTIs) and a protease inhibitor (PI). The
first successful regimens were relatively toxic, with a high pill burden and complexity
but the impact on morbidity and mortality was dramatic.
Since then, nearly 25 antiretroviral drugs (ARV) have been licensed by the US
Food and Drug Administration (FDA) for the treatment of HIV-1 [48]: nine nucleo-
side reverse transcriptase inhibitors (NRTI), four nonnucleoside reverse transcriptase
inhibitors (NNRTI), nine protease inhibitors (PI), one fusion inhibitor, one CCR5
inhibitor, and one integrase inhibitor. The first CCR5 and integrase inhibitors were
approved in 2007, increasing the number of ARV classes from four to six.
1.2.2 Emergence of drug resistance
With HIV, drug resistance is caused by changes in the virus’s genetic structure
[1, 4]. When HIV reproduces, it makes new copies of its genetic material. But HIV
does not always make perfect copies of itself since it does not contain the proteins
needed to correct the mistakes it makes at the reverse transcription step. Lots of small
mistakes can be made. These mistakes are called mutations and will create a mutant
strain. They occur naturally and make the new virus just a little bit different from
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the old virus. Mutations are very common in HIV. This is because HIV replicates at
an extremely rapid rate. In a person with HIV who is not taking ARV drugs, billions
of copies of HIV are made every day. Mutations occur by chance. The more virus
that is made, the more likely it is that a ’mutant’ strain will appear.
Mutations occur randomly, on a daily basis, but many are harmless. In fact,
most mutations actually put HIV at a disadvantage. They reduce the virus’s ’fitness’
and slow its ability to infect CD4+ cells in the body. However, a number of mutations
can give HIV a survival advantage when ARV drugs are used, because these mutations
can block drugs from working against the HIV enzymes they are designed to target.
These are the mutations we are concerned with when we talk about drug resistance.
The wildtype virus refers to the most common strain of virus that HIV-
infected people have as the predominant strain when they are taking no ARV drugs.
Anything different from the wildtype is considered a mutation.
Sometimes a mutant version of HIV is resistant to more than one drug. When
this happens, the drugs are called cross-resistant. For example, most HIV that is
resistant to nevirapine (Viramune) is also resistant to efavirenz (Sustiva). This means
that nevirapine and efavirenz are cross-resistant.
1.3 Resistance testing
A phenotype is any observable characteristic or trait of an organism: such
as its morphology, development, biochemical or physiological properties, or behavior.
Phenotypes result from the expression of an organism’s genes as well as the influence
of environmental factors and possible interactions between the two. The genotype
of an organism is the inherited instructions it carries within its genetic code. It repre-
sents an organism’s exact genetic makeup, and contains an organism’s full hereditary
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information, even if not expressed.
There are simple blood tests that can detect HIV resistance and help clini-
cians identify which HIV medications will work best against the mutant virus. Two
main types of resistance testing are now available: phenotype testing and genotype
testing [2]. Phenotype testing looks at drug resistance in vitro, measuring the ex-
tent to which specific drugs or drug combinations inhibit viral replication in cultured
cells. Genotype testing analyzes the sequence information of the virus, inferring drug
resistance from mutations associated with resistance.
1.3.1 Phenotypic testing
Phenotypic analysis determines the degree to which a drug inhibits replication
of the patient’s virus. The concentration of the drug required to inhibit the virus
replication by 50% is called the IC50. One usually measures IC50 for a patient virus
sample, in comparison to IC50 required for a wildtype reference strain. Then the fold





The clinical cut-off refers to the FC of virus susceptibility above which the
drug has less activity in vivo. Often there are two cut-offs. Virus with a fold-change
in susceptibility below the lower cut-off is fully susceptible, while virus with a FC in
susceptibility above the higher cut-off is very unlikely to be inhibited at all. Virus
with a fold-change between the cut-offs is partially susceptible.
Advantages of phenotypic testing for resistance include relatively easy inter-
pretation, the ability to provide quantitative information on the degree of resistance,
the ability to assess interactions among resistance mutations on overall resistance and
susceptibility, and the fact that it does not require an understanding of genotypic cor-
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relation of resistance.
One of the limitations of the use of phenotypic resistance tests is that clinical
cut-offs have not been clearly established for some of the NRTIs or PIs.
1.3.2 Genotypic testing
In genotype testing, the reverse transcriptase and protease samples are se-
quenced. The genotype assay returns either the RNA sequence data or a list of the
differences from the wildtype sequence.
HIV genotypic assays detect known mutations associated with drug resistance.
Genotypic assays are commonly used for detection of ARV drug resistance because
of lesser cost as compared to phenotypic assays and rapid turnaround time. The
sensitivity of most of these assays range between 100-1000 viral RNA copies/ml.
These assays involve detection of mutations in the HIV-1 genome, in the regions that
are targeted by the different ARV drugs, namely PR and RT.
1.4 Data representation
Throughout this article we consider genetic variation in the viral pathogen,
rather than in the host. Specific mutations between PR positions 10-93 and RT
positions 41-236 are associated with resistance to PIs and RTIs, respectively.
1.4.1 Stanford HIV Database (HIVdb)
The HIVdb is a public web-based interpreting system at Stanford University
that stores sequences of the PR and RT genes (http://hivdb.stanford.edu/). The
web-based system interprets the user-entered mutations to infer levels of resistance
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to the available drug classes: NRTIs, NNRTIs and PIs.
The database is designed to store, analyze and make available the diverse forms
of data underlying drug resistance knowledge to the broad community of researchers
and clinicians studying HIV drug resistance and using HIV drug resistance tests. It
also provides a publicly available online resource to help those performing HIV drug
resistance surveillance, interpreting HIV drug resistance tests, and developing new
ARV drugs.
As of March 2009, HIVdb contains 51402 RT sequences, 52046 PR sequences,
3215 Integrase sequences from more than 80,000 distinct virus isolations obtained from
nearly 40,000 individuals. 98%-99% of the viruses are human HIV-1 isolates; 1%-2%
of viruses are human HIV-2 isolates or other non-human primate lentiviruses (NHPL).
The HIVdb also contains 1691198 mutations including 1036762 RT mutations, 590885
Protease mutations and 63551 Integrase mutations.
1.4.2 Data representation
Resistance mutations are described as a letter corresponding to wildtype virus
amino acid preceding a number, which shows the position of the relevant codon in
the HIV-1 genome PR or RT. The succeeding letter describes the amino acid in the
mutant virus. Without cause of confusion the first letter can be omitted.
We consider HIV-1 drug resistance to the nucleoside reverse transcriptase in-
hibitor zidovudine as a test case. The most common RT mutations (”classical zidovu-
dine mutations”) that develop under zidovudine therapy are M41L, D67N, K70R,
L210W, T215F/Y, and K219E/Q. Other mutations are less frequent and typically
occur under prolonged combination therapies containing two or more nucleoside RT
inhibitors.
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In a typical setting, N samples are collected and for each sample the mutations
of genotypes are observed. Suppose there are ℓ possible mutations, say m1, . . . , mℓ.
For each sample, its genotype can be characterized as the set of mutations that occur
in this sample. We use a binary vector of length ℓ to represent this genotype, say





1 if mutation j occurs in sample Xi,
0 otherwise.
So each genotype can be either represented by a set of mutations, or by a
vector of indicator variables (it is also called a pattern in the literature [12]). We
will use both representations below. For example if the nonzero positions of X are
j1, . . . , jℓi, then X can also be represented by the set {mj1 , . . . , mjℓi}. We represent
the censored wildtype genotype by a zero vector (0, . . . , 0).
Let T = (V,E,WT ) be a tree where V = {m1, . . . , mℓ} (each vertex represents
a mutation) and WT is the root representing wildtype. A subtree T ′ = (V ′, E ′,WT )
is said to be root closed if all the vertices lie on the path from the root WT to a vertex
in V ′ are also in V ′. A genotype X is compatible with T if there is a root closed
subtree of T whose vertices are exactly the mutations occuring in X, and this subtree
is called an induced subtree of X. In [12] it is also said that X can be generated by
T . We denote by Ω = {0, 1}ℓ the set of all possible patterns of length ℓ.
Throughout this thesis we use Table 1.2 as our testing data, which was used
in [12] from an old version of Stanford HIVDB in 2003. These data were derived from
previously untreated patients under AZT mono-therapy. The sample size is N = 364.
We consider the occurrence of the following six mutants in TAMs only: 41L, 67N,
70R, 210W, 215FY, and 219EQ. There are 35 mutation patterns (maximum possible
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Table 1.2: 364 samples.
Pattern 41L 67N 70R 210W 215Y 219Q Frequency Percentage
1 0 0 0 0 1 1 1 0.275
2 0 1 0 0 0 0 1 0.275
3 0 1 0 0 0 1 1 0.275
4 0 1 0 0 1 0 1 0.275
5 0 1 0 0 1 1 1 0.275
6 1 0 0 1 0 0 1 0.275
7 1 0 1 0 0 0 1 0.275
8 1 0 1 0 1 1 1 0.275
9 1 1 0 0 0 0 1 0.275
10 1 1 1 0 0 0 1 0.275
11 1 1 1 0 0 1 1 0.275
12 0 0 0 0 0 1 2 0.549
13 0 1 0 1 1 0 2 0.549
14 1 0 0 0 0 0 2 0.549
15 1 1 0 1 1 1 2 0.549
16 0 0 0 1 1 0 3 0.824
17 0 0 1 1 1 1 3 0.824
18 0 1 1 0 1 0 3 0.824
19 1 1 0 0 1 0 3 0.824
20 1 1 1 0 1 0 4 1.10
21 1 1 1 1 1 0 4 1.10
22 0 1 1 0 0 0 5 1.37
23 1 1 0 1 1 0 5 1.37
24 0 0 1 0 0 1 6 1.65
25 0 0 1 0 1 0 7 1.92
26 0 0 1 0 1 1 7 1.92
27 1 0 1 0 1 0 7 1.92
28 0 1 1 0 1 1 10 2.75
29 1 1 1 0 1 1 11 3.02
30 0 0 0 0 1 0 14 3.85
31 0 1 1 0 0 1 23 6.32
32 1 0 0 1 1 0 25 6.87
33 1 0 0 0 1 0 30 8.24
34 0 0 1 0 0 0 60 16.5
35 0 0 0 0 0 0 115 31.6
Total 364 100
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26 = 64) consisting of these six mutants. Two mutations are present at codon 215
(Y or F). However we don’t distinguish 215F from 215Y because 215Y is prevailing.
Same reason applies for 219E and 219Q.
1.5 Computational problems and outline
The availability of massive HIV drug resistance data provides us exciting op-
portunities for HIV research. It also challenges us with its high-dimensionality. For
example the number of major mutations in RT is estimated to be 30∼40 for RTI
resistance, and around 20 for PI resistance. Genotype drug resistance testing is much
faster and cheaper, but sequence data provide only indirect evidence of resistance
and require a more detailed interpretation [37]. Mining high-dimensional data is an
urgent problem of great practical importance.
Several statistical machine learning techniques are utilized to analyze the se-
quence data in this thesis. We are interested in the following problems.
1. To identify possible covariation among residue-specific mutations.
2. To characterize viral progression pathways.
3. To predict drug resistance from viral genetic sequence.
4. To evaluate viral fitness from viral genetic sequence.
We begin with covariation study among mutations at different residues in
Chapter 2. The hierarchical random graph has been introduced for network inference,
and an optimal graph can be derived by a Markov chain Monter Carlo method. We
generalize this approach to expose the structural relation of the mutations by carefully
defined parameters.
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The accumulation of resistance-associated mutations along multiple evolution-
ary pathways is analyzed in Chapter 3. The tree inference algorithms were developed
in literature. We reveal the bias existing in previous algorithms, and then propose
our method to improve the accuracy of parameter estimations.
Predicting an organism’s phenotype from its genotype is a fundamental prob-
lem of biology. In Chapter 4 we propose a method to build a regression model from
matched genotype-phenotype pairs. The novelty of our method is that we use the
evolutionary pathways to determine coefficients for the terms in the regression func-
tion.
In Chapter 5 we approach the task of evaluating the relative viral fitness of
certain mutation patterns via computational methods. Our initial computational
results closely agree with experimental results.
Finally, several future research problems are presented in Chapter 6.
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Chapter 2
Covariation Analysis of Mutations
via Hierarchical Random Graphs
High covariation between mutations at different positions (residues) result
from a similar selective pressure, a functional interaction, or structural dependency.
Hierarchical random graphs have been introduced by Clauset et al. for network
inference and missing links prediction [16]. In an optimal hierarchical random graph,
closely related pairs of vertices have lower common ancestors in the tree than those of
more distantly related pairs. The optimal hierarchical random graph can be derived
by a maximum likelihood approach combing a Markov chain Monte Carlo algorithm.
We consider the mutations as discrete random variables. By careful definition




A strong correlation between position-specific mutations is interpreted as evi-
dence of functional interactions or structural dependency under substantial selection
pressure. Covariation analysis of mutations in different regions of HIV genome has
been widely used to infer functional interactions between different sites in a protein,
and it has identified a number of correlated mutation pairs, many of which have
known biological interactions [25, 26, 31, 35, 50, 53]. Therefore, studying covaria-
tion of amino acid mutations in HIV will improve our understanding of HIV drug
resistance as well as help vaccine design [35, 53].
Mutations associated with reduced drug sensitivity do not accumulate inde-
pendently from each other. For example, in RTI drug resistance mutations, there are
two most prominent complexes associated with NRTI resistance, the thymidine ana-
logue mutations (TAMs), groups 1 and 2, consisting of mutations M41L/L210W/T215Y
and K70R/K219Q/D67N, respectively.
In protease, drug resistance associated mutations are often classified as either
primary or secondary. Primary mutations appear early in the evolution of inhibitor
resistance. No single mutation provides high-level resistance, which is generally at-
tained only following the acquisition of one or more primary mutations in combination
with one or more secondary mutations. Secondary mutations by themselves can be
associated with low-level resistance and are common polymorphisms in untreated
populations. These latter mutations may compensate for a reduction in fitness (and
enhance resistance) or may further reduce drug sensitivity but with an additional
fitness loss [31].
Covariation between amino acid positions in protease can be caused by (i) the
specificity of the compensatory effect of one mutation for another; (ii) and additive
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reduction in sensitivity to a particular drug by two or more mutations in the presence
of drug selection; or (iii) the preexistence of a mutation creating a favorable context
for the emergence of a specific resistance mutation at another position [31].
Hierarchical random graphs have been recently introduced by Clauset et al.
for network inference and missing links prediction [16](a paper published in Nature).
The vertices of the graphs are found to correspond to known functional units, such as
ecological niches in food webs, modules in biochemical networks (protein interaction
networks, metabolic networks, or genetic regulatory networks), or communities in
social networks. Hierarchical structural study provides more information than simple
clustering, especially on hierarchy of the vertices. In an optimal hierarchical random
graph, closely related pairs of vertices have lower common ancestors in the tree than
those of more distantly related pairs. The optimal hierarchical random graph can
be derived by a maximum likelihood approach combing a Markov chain Monte Carlo
algorithm.
The algorithm in [16] is to find the hierarchical structure for an unweighted
and incomplete graph. The interaction between two vertices in a network either exists
or does not. In fact, we can consider unweighted graphs as a special case of weighted
complete graphs with weight 0 for disconnected edges and weight 1 for connected
edges. With this idea we want to generalize the algorithm to work on weighted
complete graphs.
We consider mutations as random variables, and build a weighted complete
graph with each vertex being a variable. We carefully define the distance of a pair
of vertices by their Jaccad similarity coefficient. A modified version of the algorithm




Several computational methods are proposed in this topic from different per-
spectives, see for example [31] for the pairwise covariation in protease, [38] for spectral
clustering in protease, and [44] in protease and reverse transcriptase.
2.2.1 Mutual information analysis
In [31], a total of 31 positions within HIV-1 protease was analyzed. The
protease sequences were retrieved from the Stanford HIV Drug Resistance database.
Mutual information (M) was calculated for all possible 465 pairwise combina-
tions of these 31 variable positions. M is the sum of the Shannon entropies at each
of two positions minus the joint entropy of the two positions:












p(Xi, Xj) log p(Xi, Xj)
Here m and n are the numbers of different amino acids represented at positions
X and Y , respectively. p(Xi) is the relative frequency of the amino acid i at position
X, and p(Xi, Yj) is the relative frequency of the combination of amino acid pair
Xi and Yj. The intuitive idea is that if the amino acids at the two positions vary
independently they will form many combinations and H(X, Y ) will be large, reducing
the value of M(X, Y ). On the other hand if the positions covary, there will be fewer
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combinations, and since H(X, Y ) is small, M(X, Y ) will remain relatively large.
Significance of pairwise association was assessed using permutation tests. Strong
statistical support for linkage in the treated data set was seen for 32 pairs and 9 pairs
of sites in the untreated data set. Most associations were positive, although negative
associations were seen for five pairs of interactions. Structural proximity suggests
that numerous pairs may interact within a local environment.
In addition to the mutual information analysis, Liu et al. [38] developed
spectral partitioning methods for efficient analysis of the matrices of pairwise mutual
information. The residues were partitioned into clusters, such that the similarity is
high among the nodes within a cluster and low across different clusters.
2.2.2 Jaccard similarity coefficients
The Jaccard similarity coefficient (J) was employed to assess covariation among
PR and RT mutations in [44]. For a given pair of mutations X and Y , the Jaccard




where NXY represents the number of sequences containing X and Y , NX0 represents
the number of sequences containing X but not Y , and N0Y represents the number of
sequences containing Y but not X. This coefficient represents the probability of both
mutations occurring together when either mutation occurs.
To test whether observed Jaccard similarity coefficients were statistically sig-
nificant, the expected value of the Jaccard similarity coefficients (JRAND) and its
standard error (JSE) were also calculated for each pair of mutations by assuming two
mutations (X and Y ) occur independently. JRAND was calculated as the mean Jac-
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card similarity coefficient using 2,000 random rearrangements of the X or Y vector
(containing 0 or 1 for presence or absence of a mutation, respectively). JSE was calcu-
lated using a jackknifed procedure, which removes one sequence at a time, repeatedly
for each sequence. The standardized score Z, Z = J−JRAND
JSE
, indicates a significant
positive association (if Z > 2.56) or a significant negative association (if Z < −2.56)
at an unadjusted p-value< 0.01.
A complete list of 327 statistically significant RT mutation pairs and 161 pro-
tease mutation pairs was derived, where several previously reported patterns of amino
acid covariation were confirmed and many new patterns of covariation were identified.
Multidimensional scaling further organized many of the correlations into clusters of
co-occurring mutations.
2.3 Hierarchical structure analysis
Firstly we construct a graph G with ℓ vertices corresponding to ℓ position-
specific mutations. G is a weighted complete graph. For an edge e with end points
u and v, we associate a weight wuv. There are many metrics to define this weight.
Here we use Jaccard similarity coefficient, that is
J(u, v) =
p(v|u)p(u|v)
p(v|u) + p(u|v) − p(v|u)p(u|v)
, (2.1)
where p(v|u) is the conditional probability of the occurrence of v given the occurrence
of u.
Table 2.1 lists all the pairwise Jaccard similarity coefficients of the six muta-
tions in Table 1.2.
For two sets of mutations we define the Jaccard similarity coefficient to be the
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Table 2.1: Pairwise Jaccard similarity coefficients.
wuv 41L 67N 70R 210W 215Y 219Q
41L 1 0.219 0.135 0.346 0.609 0.098
67N 0.219 1 0.363 0.117 0.260 0.495
70R 0.135 0.363 1 0.036 0.237 0.385
210W 0.346 0.117 0.036 1 0.303 0.046
215Y 0.609 0.260 0.237 0.303 1 0.203
219Q 0.098 0.495 0.385 0.046 0.203 1








Next we define a hierarchical random graph from a weighted complete graph
G analogous to the definition for unweighted graphs in [16]. It is defined through
a dendrogram D, which is a binary tree with ℓ leaves corresponding to the vertices
of G. Each of the ℓ − 1 internal vertices of D corresponds to a group of vertices
descended from it. For each internal vertex r, let Lr and Rr, respectively, be the sets
of leaves in the left and right subtrees rooted at r. We associate r with a weight wr
defined as the Jaccard similarity coefficient between Lr and Rr,






where | · | is the size of a set.
So for any two vertices u, v of G, their Jaccard similarity coefficient in D
becomes wr where r is their lowest common ancestor in D. The dendrogram D along
with the set of probabilities {pr : 1 ≤ r ≤ ℓ − 1} then defines a hierarchical random
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graph.
We need to build an objective function for evaluating a hierarchical random
graph for given data. Since Jaccard similarity coefficient can be interpreted as the
probability of both mutations occurring together when either mutation occurs, we
can follow the objective function in [16] by using likelihood function. The likelihood










wwrr (1 − wr)
1−wr]|Lr||Rr| (2.3)
with the convention that 00 = 1. For a given G, the dendrogram with maximum
likelihood is called an optimal hierarchical random graph.





where h(p) = −p log p − (1 − p) log(1 − p) is the Shannon entropy function. Note
that each term −|Lr||Rr|h(wr) is maximized when wr is close to 0 or to 1, i.e., when
the entropy is minimized. In other words, high-likelihood dendrograms are those that
partition the vertices into groups between which connections are either very common
or very rare.
The mean squared error (MSE) can be considered as an alternative objective











A dendrogram with minimum MSE is called optimal for a given G.






(a) L = 1.29 × 10−4, MSE=3.06 × 10−2






(b) L = 4.36 × 10−4, MSE=6.39 × 10−3
Figure 2.1: A small example of a hierarchical random graph.
A small example of a hierarchical random graph consisting of 6 vertices is
given in Figure 2.1, where the dendrogram in Figure 2.1(b) has larger likelihood than
in Figure 2.1(a). In fact (b) achieves global maximum likelihood and least MSE.
When the number of vertices ℓ becomes large, the number of the candidate
trees grows dramatically large to the order of ℓ! and finding an optimal tree becomes
difficult. In [16], a Markov chain Monte Carlo method is proposed. To create the
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Markov chain they pick a set of transitions between possible dendrograms. The
transitions they use consist of rearrangements of subtrees of the dendrogram. At each
step of their Markov chain, choose an internal node r (other than the root) uniformly
at random and switch a subtree descended from r with a subtree descended from a
sibling of r. The result is a new dendrogram D′. They accept the transition from D
to a new dendrogram D′ if L(D′) ≥ L(D); otherwise they accept the transition with
probability L(D
′)
L(D) . The Markov chain appears to converge relatively quickly, with the
likelihood reaching equilibrium after roughly O(ℓ2) steps. Many dendrograms can be
found with roughly competitive likelihoods. In this case they use some resampling
technique to find the optimal candidate.
Their algorithm can be applied to our study immediately in our new settings,
for both likelihood function in (2.3) or MSE in (2.5).
In summary we use the standard algorithm from [16] as followings:
1. Initialize the Markov chain by choosing a random starting dendrogram.
2. Run the Monte Carlo algorithm until equilibrium is reached.




The fundamental observation for this modeling is that viral progression is
accumulated by certain pathways. In this chapter, we first review the work of tree
inference from cross-sectional data by Beerenwinkel et al. in [12]. We then point out
the bias that may exist in the cross-sectional data. Such bias can affect the correctness
of the tree structures reconstructed by their method. We then propose a method for
improving the accuracy of the parameter estimation in the tree structure inference.
3.1 Introduction
Viral genotypes can be characterized as belonging to clinical meaningful dis-
crete states. In [12] Beerenwinkel et al. developed a method for learning viral pro-
gression pathways from cross-sectional data using a mixture trees model and achieved
considerable success. Recently, Beerenwinkel [13, 24] developed waiting time models
of viral progression using Bayesian network analysis. In their model, HIV genotypes
evolve on spanning trees. The accumulation on the trees generates different mutation
patterns. Each pattern is regarded as a different state. In another direction, Foulkes
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and De Gruttola [23] grouped sequences with similar patterns of mutation into clus-
ters to reduce dimensionality; Each cluster is treated as a super node. They then
introduce a Markov model on the super nodes that assumes an exponential hazard
for each transition. They estimate the transition rates between states.
Many resistance-associated mutations have been identified by the worldwide
effort. However, the order in which the resistance-associated mutations accumulate is
much less known. Some mutations are known to occur preferentially in clusters, but
the order of accumulation is usually unknown. A few studies based on longitudinal
(time series) data have revealed directed dependencies between mutations. For exam-
ple, under zidovudine therapy, K70R and T215F/Y are generally the first mutations
to occur. The mutations 41L, 215F/Y and 210W tend to occur together, so do 70R
and 219E/Q. Substitution M41L may also appear first though less frequently. How-
ever, in contrast to the 70R+215F/Y double mutant, the 41L+70R co-occurrence is
hardly ever observed [33].
In general, the evolution of drug resistance is driven by several factors including
codon usage bias, random genetic drift, and natural selection. Under therapy, the
viral population is exposed to a strong selective pressure. Mutations almost always
arise one at a time, and each single advantageous mutation must be fixed into the
population. Consequently, although large number of possible mutational patterns can
occur, there are only relatively few evolutionary pathways led from the wildtype to
mutants with high resistance and good replication capability [27].
The computational challenge we are facing is the limited availability of longi-
tudinal data. Longitudinal data are time series data based on repeated observations
on units observed over time. Large longitudinal samples from patients under the
same therapeutic regimen are relatively difficult to obtain. On the other hand, cross-
sectional data may come from different patients at different time points, which are
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much more abundant.
The method of tree structure inference based on cross-sectional data was in-
troduced by Desper et al. [19]. They proposed an algorithm that reconstructs the
correct tree structure from cross-sectional data. Beerenwinkel et al. generalized it to
a mixture model of trees by employing an EM-like algorithm and applied this model
to study the evolutionary pathways of HIV drug resistance [12]. This model seems to
achieve considerable succusses ([12, 13, 24]).
3.2 Previous inference methods: Pathway infer-
ence from cross-sectional data
3.2.1 Mutagenetic tree and tree reconstruction
The evolution of drug resistance is viewed as the accumulation of permanent
genetic changes in [12]. Their model uses a stochastic evolutionary process to identify
directed dependencies between mutational events. The basic building block of the
model is a directed tree. Vertices of the tree represent binary random variables,
each indicating the occurrence of an event (mutation). Each edge is weighted with
the conditional probability of the child given that the parent mutation has occurred.
Precisely, a mutagenetic tree T = (V,E,WT, p) consists of a set of vertices V =
{m1, ..., mℓ} representing mutations, a set of edges E, a special vertex WT ∈ V , and
a map p : E → [0, 1] such that
1. (V,E) is a spanning tree, i.e., a digraph whose underlying undirected graph is
a forest, and each vertex has at most one entering edge,
2. the vertex WT represents the widetype and has no entering edge,
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3. for all edges e = (u, v) ∈ E,
(a) p(e) = p(v|u) is the conditional probability of mutation v given that mu-
tation u has occurred,
(b) p(e) > 0 (if p(e) = 0, we can delete e from E),
(c) p(e) < 1 if e leaves the root (if p(v|r) = 1, mutations v and r can be
merged).













Figure 3.1: A mutagenetic tree for the development of zidovudine resistance.
A mutagenetic tree induces a probability distribution on the set Ω of all pos-
sible mutational patterns as follows. The sample space contains all the patterns that
are compatible with T . Pick each edge e independently with probability p(e). Then
the set of vertices that are reachable from the root is the outcome of the experiment.
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Desper et al. [19] showed how to reconstruct the mutagenetic tree from all
pairwise joint probabilities of mutations. Consider the complete digraph G = (V, V ×
V, w) and weight on edge (u, v) being




where p(u) denotes the marginal probability of mutation u and p(u, v) the joint prob-
ability of mutations u and v. Then the mutagenetic tree is the spanning tree in G
that maximizes the sum of its edge weights. The maximum weight spanning tree can
be computed in O(|V ||E|) time by Edmonds’ branching algorithm [22].
In practice, one does not know the joint probabilities of mutations, but have
to estimate them from the data. For sufficiently many samples, the above algorithm
will reconstruct the correct mutagenetic tree with high probability (see [19] for proofs
and a quantitative version of this statement).
3.2.2 Likelihood computation
Given a mutagenetic tree T = (V,E,WT, p), the likelihood of a pattern X of
mutations is the probability that T generates X: L(X|T ) = p(X|T ). Let S ⊂ V
be the set of mutations specified by X. If there is a subset E ′ ⊂ E such that S is
exactly the set of all vertices reachable from r in the subtree (V,E ′), then X can be








For example, for the mutagenetic tree displayed in Fig. 3.1 and the pattern
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X = {70R, 219Q}, we find
L(X|T ) = 0.46 · 0.46 · (1 − 0.43) · (1 − 0.65) = 0.045.
If there is no such edge subset, the topology of T does not allow for generating
X, and hence L(X|T ) = 0.
The likelihood computation can be done efficiently by traversing the mutage-
netic tree in a breadth-first search starting from r.
3.2.3 Mixture trees model
The tree models provide a detailed and interpretable description of the process
of accumulating genetic changes. They represent a considerable improvement over
independence or linear path models. However, a single tree model is too strict for the
noisy real world data. To overcome this shortcoming, Beerenwinkel et al. introduced
the broader class of mixture models of trees [12]. In particular, they introduced a
”noise component” that includes all otherwise unexplained samples using a star tree.
We call T a star, if all edges e ∈ E leave the root vertex r. A star models mutations
as being independent of each other.
Firstly we follow [12] to define the necessary notations. Suppose that Z1, . . . , ZK
are multivariate discrete random variables with range Ω that are distributed according
to mutagenetic trees
Tk = (V,Ek,WT, pk), k = 1, . . . , K,
respectively. Let ∆1, . . . ,∆K ∈ {0, 1} be binary random variables with p(∆k = 1) =
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that generates the random variable Z =
∑K
k=1 ∆kZk, a K-mutagenetic trees mixture
model.




The goal is to find mutagenetic trees T1, . . . , TK and mixture parameters







The responsibility of model component k for sample Xi is defined as




γik be the weighted number of samples generated by Tk.
An EM-like algorithm developed by them is presented in Figure 3.2 for learning
structure and parameters of the model from data in Table 1.2.
The stability of the EM-like algorithm is examined in [14], where the algorithm
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INPUT:
• Patterns of events X = (xij) 1≤i≤N
1≤j≤ℓ
• Number of mutagenetic treesK ≥ 2
OUTPUT:




1. Guess initial responsibilities:





, if xi is in cluster k − 1
1
2(K−1) , else.
2. M-like step. Update model parameters:
Set Nk =
∑N
i=1 γik for all k = 1, . . . , K.







For k = 2, . . . , K:
(a) For all pairs of events (j1, j2), 1 ≤ j1, j2 ≤ ℓ, estimate their joint





(b) Compute the maximum weight branching Tk from the complete
digraph with weights w derived from pk.
(c) Compute the mixture parameter αk = Nk/N .





4. Iterate steps 2 and 3 until convergence.
Figure 4.4: EM-like algorithm for learning a -mutagenetic trees mixture model from
Figure 3.2: EM-like algorithm for learning a K-mutagenetic trees mixture model [12].
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0.01, if k = 0;
0.99 · d
d+(K−2) , if xi is in cluster (k − 1);
0.99 · 1
d+(K−2) , else (the remaining (K − 2) clusters).
(3.3)
In this setting the diversity parameter d controls the softness of the initial
assignment. Simulations were performed to choose an optimal value for d.
3.3 Parameter normalization
We want to point out the bias in raw cross-sectional data used in previous
algorithms. We then propose a method to reduce the bias by normalization of the
raw data.
3.3.1 Bias on cross-sectional data
For a pattern its observing time is the time during which it can be observed.
The frequency for each pattern is determined by two main factors: the probability
induced by the true mutagenetic trees, and the length of its observing time. The
latter factor was ignored in [19] and [12], where it was assumed that the frequency of
a pattern is proportional to the likelihood of this pattern generated by the mutagenetic
trees. The bias occurs inevitably. So the precision of the parameters estimation for
the tree(s) is not clear. We illustrate how severely this bias can affect the parameters
estimation by the following example.
Suppose a true mutagenetic tree is known. Let WT represent the wildtype,
and m1, m2 represent 2 different mutations. Assume the genotype evolves in the order
33
ofWT,m1, m2, as drawn in the mutagenetic tree T in Figure 1. By this tree structure,
the only possible patterns generated by this tree are WT,X1, X2 where X1 = {m1}
and X2 = {m1, m2}. We build a specific tree model by assigning P (m1|WT ) = 1 and







P (m1|WT ) = 1
P (m2|m1) = 0.5
Figure 3.3: A timed mutagenetic tree T .
Then likelihood of patterns generated by T are
L(WT |T ) = 0,
L(X1|T ) = 1 · (1 − 0.5) = 0.5 and
L(X2|T ) = 1 · 0.5 = 0.5.
Assume the waiting time for the acquisition of m1 from WT is t where t
represents a reasonable time period, and t for the acquisition of m1m2 from m1. Thus
at the time from t to 2t, the observed pattern is X1. Suppose the study ends at 3t.
At the time from 2t to 3t, the observed patterns are X1 and X2 with equal frequency
since P (m2|m1) = 0.5. Here we assume that the clinical visits for all the patients
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in the sample distribute uniformly with respect to the time line. That is, a patient
visit the clinician at random, so the probability of the visit lies in each time interval
of (0, t), (t, 2t), (2t, 3t) is 1
3
. Let P (WT ), P (X1) and P (X2) be the probabilities of
observing WT,X1 and X2 in the sample respectively. We then have the following
calculation.













































When we reconstruct the mutagenetic tree from cross-sectional data we col-
lected, the reconstruction algorithm is still able to determine the correct structure.
However, the estimated conditional probabilities differ from the original conditional
probabilities.
P̂ (m1|WT ) =
P (X1)




P (X1) + P (X2)
= 0.25.
This is a small example with 2 vertices and moderate settings. In this exam-
ple, the tree structure (topology structure and the positions of the vertices) can be
reconstructed correctly. Only some of the parameters are wrong. In more compli-
cated examples, the algorithm may even not be able to reconstruct the tree structure
correctly. The tree reconstruction algorithm is to find the tree with maximum weight
spanning tree from a complete graph with weight w(u, v) defined in Equation (3.1).
Thus this algorithm depends heavily on the values of these probabilities, which are
affected by the bias caused by the different lengths of observing times. In large





P̂ (m1|WT ) = 0.6
P̂ (m2|m1) = 0.25
Figure 3.4: The reconstructed mutagenetic tree from data.
3.3.2 Parameter estimation
It seems more reasonable to assume that the frequency of a pattern is pro-
portional to the product of the likelihood and the observing time for this pattern.
Nevertheless, it is hard to estimate the observing time from cross-sectional data.
However, observing times may be computed using longitudinal data. Below we pro-
pose a method to reduce the bias by assuming observing times are available from
longitudinal data. We then normalize the frequency of a pattern by dividing a factor
proportional to the expected value of the length of the observing time for this pattern.
Let t(X) be the acquisition time of a pattern X from wildtype. Here our big
assumption is that t(X) can be estimated by certain approach from longitudinal data.
Some related work was done by Healy and De Gruttola in [28], where they developed
methods to incorporate interval-censored data in the setting when the exact times of
transition are unknown but known only within an interval or known with error. With
the advance of the technology the longitudinal data will become more available.
A pattern Xi = (xi1, . . . , xiℓ) can be observed in two situations. The first case
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is when Xi remains unchanged. Suppose the total length of the study is T . Then the
length of this duration is T − t(Xi). The second case is that it can be observed before
the occurrence of any of its proceeding mutations. A proceeding mutation can only
occur at the positions where xij = 0. We denote the set of these mutations to be
φ(Xi) = {mj : xij = 0}.
Thus the possible proceeding patterns after Xi are
Xi +mj = (xi1, . . . , xi,j−1, 1, xi,j+1, . . . , xiℓ), mj ∈ φ(Xi).
For example, if Xi = (1, 0, 1, 0, 0, 1), then φ(Xi) = {m2, m4, m5}, and Xi + m2 =
(1, 1, 1, 0, 0, 1).
In the second case the length of the duration is t(Xi+mj)−t(Xi). Now we want
to calculate the expected value of the length of the observing time for Xi, denoted
as θ(Xi). In a single mutagenetic tree model, suppose we are given the normalized
conditional probabilities p̄(Xi|Xi) and p̄(Xi +mj |Xi) for mj ∈ φ(Xi). Then
θ(Xi) = p̄(Xi|Xi)(T − t(Xi)) +
∑
mj∈φ(Xi)
p̄(Xi +mj |Xi)(t(Xi +mj) − t(Xi)).
If there are K mutagenetic trees Tk with mixture parameter αk, k = 1, . . . , K.
Suppose p̄k(Xi|Xi), p̄k(Xi + mj|Xi) are the conditional probabilities associated with







θk(Xi) = p̄k(Xi|Xi)(T − t(Xi)) +
∑
mj∈φ(Xi)
p̄k(Xi +mj |Xi)(t(Xi +mj) − t(Xi)).
Here we assume t(Xi) and t(Xi + mj) − t(Xi) don’t change despite the fact that
Xi may evolve through different mutagenetic trees. In fact t(Xi + mj) − t(Xi) is
not sensitive to different trees, and when T is relatively large comparing to t(Xi),
T − t(Xi) is not sensitive as well.
So θ(Xi) varies for different Xi. We want to normalize the indicator vectors
by dividing a bias factor proportional to θ(Xi), say B(Xi), which will be defined in





By this normalization performed on Xi, the bias caused by the different ob-
serving time for Xi gets reduced. Now the normalized distribution of the samples is
supposed to be identical to the probability distribution induced by the true mutage-






Let γik be the responsibility of model component k for sample Xi as defined in
(3.2) and let Nk =
N∑
i=1
γik be the weighted number of samples generated by Tk. Given
estimates of γik’s, we compute the normalized probabilities in the k-th component as














γikx̄ij1 x̄ij2 . (3.7)
Along with the weight function defined in (3.1), we can reconstruct Tk by finding the







Given an estimate of M =
K∑
k=1






















= N . Now




c·θ(Xj) = N . We can









We replace the parameters (X, pk(j), pk(j1, j2)) in the algorithm in Figure 3.2
by the normalized parameters (X̄, p̄k(j), p̄k(j1, j2)). The flow of the algorithm remains
good. The initial bias factor for each pattern is set to be 1 and will be updated iter-
atively in the E-step.
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Algorithm for learning mixture models
INPUT:
• Patterns of mutations X = (xij), 1 ≤ i ≤ N, 1 ≤ j ≤ ℓ.
• Number of mutagenetic trees K ≥ 2.
OUTPUT:






(a) Run (K − 1)-means clustering algorithm
(b) Set the initial responsibilities γik given in (3.3).
(c) Set B(Xi) = 1 for 1 ≤ i ≤ N .




γik for all k = 1, . . . , K.








For k = 2, . . . , K:
(a) X̄ = X
B(X)
.
(b) Estimate p̄k(j) for 1 ≤ j ≤ ℓ and p̄k(j1, j2) for 1 ≤ j1, j2 ≤ ℓ as defined in
(3.6) and (3.7) respectively.
(c) Compute the maximum weight spanning tree Tk from the complete digraph
with weights w using normalized probabilities derived in (b) of step 2.






(a) Compute the responsibilities as defined in (3.8).
(b) Compute B(Xi) as defined in (3.9).




Predicting Drug Resistance from
Genotypes
In this chapter we develop a regression model for predicting phenotypic drug
resistance from genotypes. The novelty of our method is that we use the evolutionary
pathways to determine the coefficients for the terms in the regression function. The
model combines several linear regression models, but the model itself is not linear any
more.
4.1 Introduction
Considerable attention has been focused on predicting phenotypic drug re-
sistance from genotypes. This research is essential to developing new antiretroviral
drugs and optimizing the use of current drugs. Typical predicting approaches include
decision trees [9], linear regression [51, 54], linear discriminant analysis [47], neural
networks, support vector regression (SVR) [8], ridge regression, principal component
analysis, and some non-parametric methods [20].
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Phenotypic drug susceptibility testing provides a direct and quantitative mea-
sure of the viral behavior in vitro, however, the assays are costly and time-consuming.
Several practical difficulties have obstructed its adoption. Phenotype assays are very
expensive, costing $700 to $900 per sample. In addition, the testing procedure is
complex and only offered by a few companies. Furthermore, processing time can take
as long as 8 weeks. Unless these issues can be significantly changed, there is little
chance that phenotype testing can possibly be adopted on a widespread basis.
On the contrary, genotype testing has enjoyed much wider usage because the
procedure is much simpler, the costs are lower, and the processing time is shorter.
Genotype assays typically cost around $400 and take 1-2 weeks for processing. A
recent cost benefit analysis supported genotypic testing after treatment failure. These
factors suggest that genotype testing will continue to be a more common method.
4.2 Previous linear regression models
Various genotypic interpretation algorithms have been developed for this study.
We review below in details the algorithms in [51, 54] using linear regression models.
Both studies follow the general settings of a multiple linear regression modeling: A
dependent variable is expressed as a linear combination of independent variables and
an intercept. Both models treat the natural logarithm of FC (defined in (1.1)), log FC,
as a linear combination of position- and type-specific mutations plus a constant.
In this case, the independent variables mutj are terms representing the presence of
mutations in a genetic sequence (In our language, we use xij to be the indicator
variable for a pattern Xi with respect to a mutation mj). The model assigns a
coefficient aj, or weight, to each mutation corresponding to its contribution to the
log FC. The intercept a0 represents the FC prediction for a wild type sequence lacking
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any susceptibility altering mutations. See Equation (4.1).
log FC = a0 + a1mut1 + a2mut2 + · · ·+ anmutn (4.1)
4.2.1 Simple linear model
Wang et al. [51] used a linear regression model to investigate the relationship
between HIV genotype and drug resistance. They built a full regression model based
on current knowledge about HIV drug resistance. In this model, the dependent
variable, log FC, were determined by either Virologic’s PhenoSense assay or Virco’s
Antivirogram assay. To reduce the number of independent variables in their regression
model, they only used mutations in ’important’ positions that are known to influence
drug resistance. In a few cases where the sequence contained a mixture of two or more
amino acids at the same position, they took the value of each of the corresponding
indicator variables to be 1.
They used a backward stepwise regression method to optimize the parameters
for each independent variable and the constant. The stepwise regression begins with
the full model, where all independent variables are contained in the model. In each
subsequent step, the removal statistic is computed for each independent variable
eligible to be removed from the model, and the variable with the highest removal
statistic is removed from the current model if it is more than a critical removal value.
Then the entry statistic is computed for each independent variable that is not included
in the current model, and the variable with the lowest entry statistic is added into the
current model if it is lower than the entry statistic. The stepwise regression procedure
stops if neither entry nor removal is possible. The remaining variables comprise the
reduced model. They used the P -value as the entry and removal statistic, which
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indicates the possibility of observing such data when such variable is not associated
with the dependent variable. The critical P -values for removal and entry were set to
0.051 and 0.05, respectively. Regression analysis and data manipulation were done
using the statistics software STATA.
They collected 5507 genotype-phenotype paired records covering 17 anti-HIV
drugs from the Virologic dataset. They constructed a separate regression model for
each drug and checked the validity of these models.
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Figure 4.1: Scatter plot of experimental versus predicted resistance values
Their model performed well despite the absence of statistical terms for inter-
action effects. The scatter plots in Figure 4.1 also demonstrated the good correspon-
dence between the experimental values and their quantitative predictions. Their tests
on an independent dataset show that their method outperformed six other publicly
available HIV genotypic interpretation algorithms for most drugs at predicting drug
resistance in published datasets.
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4.2.2 Linear model considering interactions
In a similar manner, Vermeiren et al. [54] applied linear regression modeling
to predict the HIV-1 resistance phenotype from the viral genotype. In their approach,
the quantitative phenotypic measurement is also estimated as the weighted sum of the
effects of individual mutations, see (4.1). The difference from [51] is that the second
order interaction terms (mutation pairs) were included to account for synergistic
and antagonistic effects between mutations. The most significant mutations and
interactions identified by the linear regression models for 17 approved antiretroviral
drugs are reported, and their negative or positive impact on the FC is quantified by
a resistance weight factor.
Linear regression models were calculated by selecting mutations having a sig-
nificant contribution to the log FC and determining the magnitude of their effect.
Linear regression models per drug were calculated in two steps. A first model was
calculated using single mutations only. Based on the mutations that proved to be
significant in this model, mutation pairs (simultaneous presence of two mutations)
were subsequently created to assess the importance of interaction terms in addition
to single terms in a second order regression step. These interaction terms account for
synergistic and antagonistic effects between mutations. Parameter selection for both
steps was based on mutation prevalence in the data sets.
The number of terms was arranged as follows. For relatively old drugs having
larger data sets, at least 20 single mutations were considered, and 10 for relatively
new drugs (namely LPV, FTC, ATV, TPV and DRV) having smaller data sets. The
same minimal count per drug was applied to pairs, where in addition every mutation
of the pair had to be present at least 20 (or 10) times in the data set without the
other.
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Linear regression models were calculated using stepwise regression utilizing
SAS. In this method, the independent variables are alternately added to and re-
moved from the growing model based on statistical threshold values (P -value). In
each forward step, the most predictive parameter is chosen, and in the subsequent
backward step, the more stringent P -values allow elimination of the least predictive
variables.
4.3 Tree-specific linear model
First we want to formulate the problem precisely. For each genotype Xi, let
Yi be the the corresponding phenotype, say logFC. Suppose that we are given N
sample pairs (Xi, Yi), i = 1, . . . , N . We want to find a regression function F so that
F (Xi) = Yi + εi. We hope F satisfies the following properties:
1. The number of terms of F is small, and these terms represent the major factors





3. F can predict drug fold resistance, that is, for a genotype X 6= Xi, i = 1, . . . , N ,
F (X) approximates to phenotype of X.
We will use information from the evolutionary pathways, i.e. the mutagenetic
trees, to determine the terms in the regression function F . In the following a set of
mutations represents a pattern in which exactly these mutations occur.
In Chapter 3, tree models are introduced to identify the progression of the
mutations. Due to high selective advantage, if there is any correlation or interaction
between two mutations, then it is not likely that these two mutations occur inde-
pendently. This means that one mutation must be a descendant of the other in a
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tree representation. In other words, if two mutations occur independently, then the
value of F is linear on their individual presence. We illustrate this assumption by
two examples. Suppose m1 and m2 are the children of the root. It is reasonable to
assume that the increment on F when m1 evolves from the wildtype is independent
of the presence of m2 and vice versa. Thus
F (m1) − F (WT ) = F (m1, m2) − F (m2). (4.2)
WT
m1 m2
Figure 4.2: m1 and m2 are independent.
In another situation, suppose m1 is a child of the root and m2, m3 are children
of m1. So m2, m3 are independent conditionally on m1. Hence the increment on F
when m1 evolves to m1, m2 is independent on the presence of m3. Thus




Figure 4.3: m2 and m3 are independent conditionally on m1.
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Equations (4.2) and (14) can be extended to more general situation by recur-
sion. The evolution of a viral genotype is the accumulation of mutations. Given a
tree T , suppose in the next step a mutation mj2 will occur after mj1. Then the incre-
ment on F from current pattern to the next pattern is an invariant. It is independent
of the presence of any mutation outside the path from WT to mj1 . For an edge of
T with endpoint mj , we associate it with an increment function, say δ(mj). If the
data are generated by a single tree, then there are only ℓ + 1 terms in the regres-
sion function. With sufficient input, δ(mj)’s and F (WT ) can be learned by some
classical approaches, for example, the least square method. Then for a genotype




xjδ(mj) + F (WT ).
Our independent assumption is similar in spirit to the one in Sec 2.3 of [29],
where they assume that the probability of acquiring a mutation at a branch does not
depend on the presence of a mutation at another branch which meets the first branch
at the root. Relaxation of our assumption requires either additional trees (which will
be discussed below) or allowing error.
Our analysis shows that if the genotypes are generated by a single tree, then
a linear regression model is reasonable. This provides a support for the good perfor-
mance of the linear regression model in [51].
However, previous studies already suggested that mixture model of trees is
necessary [12]. Our model can be naturally generalized to a mixture model of trees.
For two patterns X1 and X2, define their union by
X1 ∪X2 = (max{x1j , x2j} : j = 1, . . . , ℓ).
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Suppose there areK mutagenetic trees and T1 is the star representing the noise




Xk is generated by Tk. Since T1 can generate all possible patterns and each mutation
occurs independently, we choose T1 with least priority. Still the decomposition is not
unique. For example, suppose the mutagenetic trees are given in Figure 4.4. For a
pattern Xi = (0, 0, 1, 0, 1, 1), it can be decomposed as
1. Xi = X
3
i = (0, 0, 1, 0, 1, 1),






i = (0, 0, 1, 0, 0, 1) and X
3
i = (0, 0, 1, 0, 1, 0), or






i = (0, 0, 1, 0, 0, 1) and X
3
i = (0, 0, 0, 0, 1, 0).
We have to set up certain rules for selection of decompositions. It is desirable
that each induced subtree by Xki in Tk is in a sense of maximality. For a mutagenetic
tree Tk, we define ψ(Tk) to be the set of patterns that are compatible with Tk. That
is,
ψ(Tk) = {X : X is compatible with Tk}.
Here we view Xi as a set of mutations. For k ≥ 2, we define X
k
i for a pattern
Xi to be the maximal X ∈ ψ(Tk) such that X ⊂ Xi.
Xki = max{X ∈ ψ(Tk) : X ⊂ Xi}. (4.4)
Note that for given Xi and ψ(Tk), X
k
i can be uniquely determined. For k = 1, let



















Figure 4.4: Three-mutagenetic trees mixture model.




i . Now we view Xi and X
k
i ’s as binary vectors.















In a classical linear regression function, for a pattern Xi, there is only 2 choices
for the coefficient of a mutation mj :




δ(mj) if xij = 1,
0 otherwise.
In our model, for a patternXi, the coefficient of a mutationmj is a combination
of up to K coefficients. That is,
∑K
k=1 δk(mj), where








Thus the total number of possible combinations for mj becomes 2
K . This provides
more flexibility for the regression model. However, we need only to find K(ℓ + 1)
undetermined coefficients. The parameter learning can use classical approaches for
parameter learning for a simple linear regression model, like the least square method.
In summary, for given mutagenetic trees Tk, k = 1, . . .K and sample pairs
(Xi, Yi), i = 1, . . . , N , our regression model contains the following steps:






i ’s are defined in (4.5) and
(4.4).
2. Build the regression function defined in (4.6), and learn the undetermined co-
efficients δk(mj)’s and Fk(WT )’s.
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4.4 Discussion
For multiple mutagenetic trees, the linearity in our model actually is de-
stroyed. That is, for two mutations m1 and m2, F (m1 + m2) may not necessarily
equal F (m1) + F (m2). Only in a single tree model, our regression model degener-
ates to a simple linear regression model, like the one in [51]. This makes us believe
that the performance of our method for multiple tree models is comparable to the
performance of [51], which outperformed 6 other algorithms. This also provides some
reason why their linear regression model can have good performance.
Another way to view the difference of our regression function from classical
linear regression functions in [51] is, even the same mutation in different patterns
might have different effects on F . It really depends on which tree this mutation lies
in at the decomposition step.
Our regression function uses at most K(ℓ+ 1) terms in total. In [45], second-
order polynomials were proposed to model interactions between each of the input
mutations using Least Angle Regression method. The number of terms of the regres-
sion function becomes ℓ2. The number of major mutations in RT is estimated to be
30∼40 for RTI resistance. This produces either a large regression function or long
process of term selection.
The goodness of our regression model depends heavily on the correctness of the
topological structures of the mutagenetic trees. The parameters (mixture parameters,
conditional probabilities) of the trees can be ignored. Cross-validation method can be
used for performance test. The accuracy of the models in predicting the phenotype
can be expressed as the mean squared error (MSE), with the error being defined as
the difference between prediction and measurement. The MSE is calculated both on
the data set used for training the models (seen data) and on unseen data in a 10-fold
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cross-validation. In the cross-validation, 10 models are generated on 90% of the data
and the MSE is calculated on the remaining 10%. The mean of those 10 MSE values
serves as a measure for the error on unseen data of the reported model (trained on
all data).
Regression models encounter a common problem that they cannot be used
for novel rare mutations that are not included in the training process. Classification
methods can be considered for treating minor strains, both for data training and for
the prediction. Hopefully with the increasing size of public databases, this problem




Relative Fitness of Mutation
Patterns
Determining the fitness of drug-resistant HIV-1 strains is necessary for the
development of population-based studies of resistance patterns. We propose a method
with quantitative measurement for the viral fitness. Our initial computational results
closely agree with the experimental results from [41] and [32].
5.1 Introduction
The short life cycle and high replicative error rate of human immunodeficiency
virus type 1 (HIV-1) cause the virus to mutate very rapidly, resulting in a high ge-
netic variability of HIV. Most of the mutations either are inferior to the parent virus
or convey no advantage, but some of them have a natural selection superiority to
their parents and can enable them to slip past defenses such as the human immune
system and escape from the anti-retroviral drugs. The more active copies of the virus,
the more resistant to anti-retroviral drugs. The fitness of a mutation is interpreted
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as the replication capability, or by how well it can fit the environment. Determin-
ing the fitness of drug-resistant HIV-1 strains is necessary for the development of
population-based studies of resistance patterns [18], and it has potential application
for therapeutic strategies.
All currently recommended anti-retroviral drugs therapy protocols employ re-
verse transcriptase inhibitors (RTIs). However, mutations within the reverse tran-
scriptase (RT) domain can lead to resistance to these agents and treatment failure
[36, 46, 17]. Zidovudine (AZT) is the first approved nucleoside analogs inhibitor
(NRTI). For zidovudine an accumulation of multiple mutations is required to confer
high-level resistance [36, 34]. Resistance to NTRIs develops either through enhanced
excision of chain terminators (thymidine analog mutations, TAMs), e.g., 41L, 67N,
70R, 210W, 215FY, and 219EQ, or by causing lower binding affinity, e.g., 184V, 65R,
and 74V [42].
Paintsil et al. (2006) utilized a reproducible, systematic real time RT/PCR-
based assay that allows the relative contribution of mutant viral fitness and drug
resistance as selective pressures underlying resistance patterns of HIV-1 [18], to mea-
sure these forces for mutations that confer resistance to nevirapine and zidovudine,
and found that viral fitness does play a role in the evolution of resistance to these
inhibitors.
Conventional laboratory methods are resource and time consuming, and ex-
periments in vitro may not reflect the natural viral response in vivo. On the other
hand, advanced sequencing technologies produce rich sequence data. It is desirable
to find the knowledge hidden in the data using computational approaches. In this
study we propose a computational method to determine the relative fitness of dif-
ferent mutation patterns of HIV-1 in the presence of AZT. We first use a clustering
method to determine the groups, namely TAM 1 and TAM 2. Next, we employ an
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EM algorithm to find an optimal model to fit the data. Then for a certain mutant
pattern, we define a quantitative measure to reveal the relative fitness of that mutant
pattern. Our computational results strongly agree with the experimental results from
two independent studies [41] and [32].
5.2 Results
We use the same data that was used in [12] (Table 1.2).
Our computational results show that in the presence of AZT, in TAMs pathway
1 (41L, 210W, 215Y), the triple mutants 41L + 210W + 215Y appear fitter than the
double mutants 41L + 210W or 210W + 215Y. And in TAMs pathway 2 (67N, 70R,
219Q), the triple mutants 67N + 70R + 219Q is fitter than the double mutants 67N
+ 70R or 67N + 219Q as well. The multiple mutants in TAM 1 out-compete the
multiple mutants in TAM 2.
Our computational results strongly agree with the experimental result from
[41], which showed that the fitness of four selected multiple mutation patterns in the
presence of AZT is in the following order: 41L + 210W + 215Y > 210W + 215Y >
67N + 70R + 219Q > 67N + 70R. The only exception is that our result is against
67N + 70R> 70R. We try to explain this in the Discussion section.
In another independent study [32], it is showed that in the fitness comparison,
41L+210W+215Y > 41L+215Y and 67N+70R+219Q > 67N+70R+210W+219Q.
Our results agree with these.
See table 5.1 for all the comparisons. For each comparison a yes or no in the
column of consistence indicates whether or not our computational result agrees with
the experimental result.
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Table 5.1: Experimental results v.s. computational results.
Reference Comparisons Our scores Consistence
[41] 41L+210W+215Y > 41L+215Y 1.21 > 1.09 yes
[41] 41L+215Y > 67N+70R+219Q 1.09 > 0.944 yes
[41] 67N+70R+219Q > 67N+70R 0.944 > 0.772 yes
[41] 215Y > 67N+70R 0.874 > 0.772 yes
[41] 67N+70R > 70R 0.772 < 1.06 no
[32] 41L+210W+215Y > 41L+215Y 1.21 > 1.09 yes
[32] 67N+70R+219Q+215F > 67N+70R+219Q 2.97 > .944 yes
[32] 67N+70R+219Q > 67N+70R+219Q+210W 0.944 > 0 yes
[32] 67N+70R+219Q+215F > 67N+70R+219Q+210W 2.97 > 0 yes
5.3 Method
5.3.1 Clustering algorithm to determine TAMs
In the literature, TAMs have been found to cluster into two main groups
[15, 26]. These are 41L, 210W, 215Y (pathway 1) and 67N, 70R, 219Q (pathway 2).
Without this information we can also derive these clusters from our data by some
standard clustering approach. For convenience we assume the mutants 41L, 67N,
70R, 210W, 215Y, and 219Q are represented by m1, m2, m3, m4, m5, m6 respectively.
For two mutants mi and mj , we construct the following contingency table 5.2 and
define the distance dij to be the Chi-squared test score.
Table 5.2: Chi-squared test for independence of mi, mj .
percentage (neither of mi,mj occurs) percentage (only mj occurs)
percentage (only mi occurs) percentage (both mi,mj occur)
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By such definition of distance, the smaller of dij, the more likely the mutants
mi and mj are independent with each other. All the pairwise distance is in the
following table.
Table 5.3: Chi-squared test and p-values.
dij 41L 67N 70R 210W 215Y
67N 0.025(0.87)
70R 0.22(0.64) 0.15(0.70)
210W 0.22(0.64) 0.0043(0.95) 0.041(0.84)
215Y 0.45(0.50) 0.040(0.84) 0.0020(0.96) 0.20(0.65)
219Q 0.0035(0.95) 0.50(0.48) 0.22(0.64) 0.0057(0.94) 0.016(0.90)
Next we construct a complete graph G whose vertices are the six single muta-
tions and whose weight on the edge eij is the distance dij. We then remove the edges
with smaller weight from G in an increasing order and determine the groups using
some clustering approach, for example the one in [39]. Nevertheless, for our case, it
is clear that two groups are perfect, with only one exceptional edge (edge 1-3). In





Figure 5.1: Weighted graph.
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5.3.2 EM algorithm
We now know that a mutant in TAM 1 occurs relatively independent on the
occurrence of another mutant in TAM 2. It is not necessary to assume they are
completely independent. Instead, we will use the incompleteness on independence to
measure the degree in which a pattern presents. The measurement should also reveal
its relative fitness.
Table 5.4: The observed probabilities of all patterns.
oij wta 41L 210W 215Y 41L/210W41L/215Y210W/215Y41L/210W/215Y
wtb .316 .00550 0 .0385 0 .0824 .00824 .0687
67N .00275.00275.00275.00275 0 .00824 .00550 .0137
70R .165 .00275 0 .0192 0 .0192 0 0
219Q .00550 0 0 .00275 0 0 0 0
67N/70R .0137 .00275 0 .00824 0 .0110 .00324 .0110
67N/219Q .00275 0 0 .00275 0 0 0 .00550
70R/219Q .0165 0 0 .0192 0 .00275 0 0
67N/70R/219Q .0632 .00275 0 .00275 0 .0302 0 0
Note that we have 64 possible mutation patterns, and each of them can be
expressed by the combinations of one pattern from TAM 1 and another one from TAM
2. More precisely, in TAM 1, let patterns Xi : i = 1, . . . , 8 represent the patterns
wildtype, m1, m4, m5, m1m4, m1m5, m4m5, m1m4m5 respectively. And the simulated
probability for pattern Xi is denoted by ai. For example, m1m4m5 represents the
triple mutants 41L + 210W + 215Y, and its simulated probability is a8. In a similar
manner in TAM 2, let patterns X̄i : i = 1, . . . , 8 represent the patterns wildtype,
m2, m3, m6, m2m3, m2m6, m3m6, m2m3m6 respectively, and bi for the simulated
probability of X̄i. Let oij be the observed probability of the mutation pattern Xi∪Xj
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(defined as Xi ∪ Xj = (max{xi1, xj1}, . . . ,max{xi6, xj6})), where Xi is from TAM 1
and Xj is from TAM 2. We build a contingency table 5.4 for all the values of oij’s.
A 0 means the corresponding pattern is not detected in the data.
We want to find the simulated probabilities of the patterns that can best





is minimum. This problem can be done by employing EM algorithm.
Algorithm for parameter estimation of an optimal model
1. Set initial values ai =
8∑
j=1






















3. Output ai, bj .
By iterations, the sum of squares converges very quickly. The result is shown in Table
5.5. This model covers around 78% of the original data. Note that if TAM 1 an TAM
2 are completely independent then the model can cover 100% of the data in theory.
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Table 5.5: EM result.
a1 a2 a3 a4 a5 a6 a7 a8
.622 .0120 .000317 .0860 0 .154 .0148 .111
b1 b2 b3 b4 b5 b6 b7 b8
.512 .0112 .249 .0849 .0286 .00593 .0286 .108
5.3.3 Fitness score function
For a pattern Xi ∪Xj, the observed probability is oij and the simulated prob-
ability is aibj . Take a consideration on the ratio
oij
aibj
. The higher it is, the relatively
more the pattern over present, and the higher fitness it should have. By this intuition






W 41L 210W 215Y 41L/210W 41L/215Y 210W/215Y 41L/210W/215Y
W 0.993 0.892 0 0.874 0 1.04 1.09 1.21
67N 0.392 20.3 769 2.84 0 4.73 32.9 11.0
70R 1.06 0.917 0 0.898 0 0.500 0 0
219Q 1.04 0 0 3.77 0 0 0 0
67N/70R 0.772 7.98 0 3.35 0 2.49 19.4 3.48
67N/219Q 0.745 0 0 5.39 0 0 0 8.39
70R/219Q 0.926 0 0 7.81 0 0.621 0 0
67N/70R/219Q 0.944 2.12 0 2.97 0 1.82 0 0
For example, the pattern 67N + 70R + 219Q+215F is made up of the pattern
215F from TAM 1 and 67N + 70R + 219Q from TAM 2. In particular, we treat the
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pattern 41L+210W+215Y as a combination of a pattern from TAM 1 and a wildtype
pattern from TAM 2. Although wildtype indicates no mutation occurs, it is still a
genotype and has biochemical properties. For the patterns with oij = 0, we simply
put 0 as its relative fitness score. The computational result is shown in Table 5.6.
For the patterns with 0 < oij < 1%, our method might not be reliable because
since the score function becomes extremely sensitive because of the small value of
denominator. Thus we remove these scores and leave as blanks. This results in Table
10.
Table 5.7: Reliable scores.
W 41L 210W 215Y 41L/210W 41L/215Y 210W/215Y 41L/210W/215Y
W 0 0.874 0 1.04 1.21
67N 0 11.0
70R 1.06 0 0.898 0 0.500 0 0
219Q 0 0 0 0 0 0
67N/70R 0.772 0 0 2.49 3.48
67N/219Q 0 0 0 0 0
70R/219Q 0.926 0 0 7.81 0 0.621 0 0
67N/70R/219Q 0.944 0 2.97 0 1.82 0 0
From Table 5.7 we predict that the patterns 41L+210W+215Y+67N and
70R+219Q+215Y have very large relative fitness scores.
5.4 Discussion
In our method, higher score means the corresponding pattern has relatively
better fitness and higher resistance to a drug. Thus once a patient has such mutation
pattern in his/her plasma, it is not wise to apply this drug to this person.
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Since we are working on cross-sectional data, our method also suffers from the
bias problem. Several studies shows that 70R is generally the first mutation to occur.
It is possible that this mutation is over observed, which leads to higher relative fitness
score according to our formula (5.1).
We have only applied our method to the mono-therapy of AZT. Current treat-
ment usually involves a combination of multiple drugs. Our future work is to gener-





This thesis aims at development of methods for interpretation of HIV genotype
data from several perspectives. Some are improvement of previous results and some
are newly developed. We describe several related problems that remain challenging.
Cross-resistance. To my knowledge there are no computational models for
this study so far, though cross-resistance is prevailing under current drug therapy.
For example, the area of pathway inference, or the drug resistance prediction under
multi-drug environment remains untouched.
TB-HIV co-infection. HIV and Tuberculosis (TB) have variously been re-
ferred to as ’the terrible twins’ and ’Bonnie and Clyde’. Among the people died of
tuberculosis in 2006 worldwide, it is estimated that 200,000 were infected with HIV.
TB is the leading cause of death among HIV infected people in Africa. The TB-HIV
co-infection crisis is twice as big as previously thought. In 2007, there were at least
1.37 million cases of HIV-positive TB, or nearly 15 percent of the total incident cases
[7]. That’s double the previous WHO estimates.
When someone is infected with TB the likelihood of them becoming sick with
the disease is increased many times if they are also HIV positive. Each disease speeds
67
up progress of the other: TB shortens the survival time of people with HIV/AIDS,
killing up to half of all AIDS patients worldwide; HIV-positive people have increased
likelihood of acquiring new TB infection, are more likely to develop active TB, and
relapse if previously treated. Having HIV makes the diagnosis of TB more complex,






Appendix A Maximum Likelihood Estimation for
Latent Class Models: Solving 100 Swiss
Francs Problem
Abstract
Sturmfels offered 100 Swiss Francs in 2005 to a conjecture, which deals with a
special case of the maximum likelihood estimation for a latent class model. A positive
solution for this conjecture is presented in this paper.
A.1 The conjecture and its statistics background








over the set of all 4× 4-matrices P = (pij) whose entries are nonnegative and sum to
1 and whose rank is at most two. Based on numerical experiments by employing an
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is a global maximum of L(P ). He offered 100 Swiss francs for a rigorous proof in a
postgraduate course held at ETH Zürich in 2005.
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Partial results were given in the paper [2], where the general statistical back-
ground for this problem is also presented. This problem is a special case of the max-
imum likelihood estimation for a latent class model. More precisely, by following [2],
let (X1, . . . , Xd) be a discrete multivariate random vector where each Xj takes value
from a finite state set Sj = {1, . . . , sj}. Let Ω = ⊗
d
j=1Sj be the sample space. For
each (x1, . . . , xd) ∈ Ω, the joint probability mass function of (X1, . . . , Xd) is denoted
as
p(x1, . . . , xd) = P{(X1, . . . , Xd) = (x1, . . . , xd)}.
The variables X1, . . . , Xd may not be mutually independent generally. By introducing
an unobservable variable H defined on the set [r] = {1, . . . r}, X1, . . . , Xd become
mutually independent. The joint probability mass function in the newly formed
model is
p(x1, . . . , xd, h) = P{(X1, . . . , Xd, H) = (x1, . . . , xd, h)}
= p(x1|h) · · · p(xd|h)λh
where λh is the marginal probability of P{H = h} and p(xj |h) is the conditional
probability P{Xj = xj |H = h}. We denote this new r-class mixture model by
H. The marginal distribution of (X1, . . . , Xd) in H is given by the probability mass
function (which is also called accounting equations [3])
p(x1, . . . , xd) =
∑
h∈[r]
p(x1, . . . , xd, h) =
∑
h∈[r]
p(x1|h) · · ·p(xd|h)λh.
In practice, a collection of samples from Ω are observed. For each (x1, . . . , xd),
let n(x1, . . . , xd) ∈ N be the number of observed occurrences of (x1, . . . , xd) in the
samples. While the parameters p(x1|h),· · · , p(xd|h), λh, p(x1, . . . , xd) are unknown.
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The maximum likelihood estimation problem is to find the model parameters that





p(x1, . . . , xd)
n(x1,...,xd).
Since each p(x1, . . . , xd) is nonnegative, it is equivalent but more convenient




n(x1, . . . , xd) ln p(x1, . . . , xd), (2)
where we define ln(0) = −∞. Finding the maxima of (2) is difficult and remains
infeasible by current symbolic software [1,4]. We can only handle some special cases:
small models or highly symmetric table. The 100 Swiss francs problem is the special
case of H when d = 2, S1 = S2 = {A,C,G,T}, s1 = s2 = 4 and r = 2. It is related
to a DNA sequence alignment problem as described in [5]. In that example, the
contingency table for the observed counts of ordered pairs of nucleotides (i.e. AA,
AC, AG, AT, CA, CC, · · · ) is







4 2 2 2
2 4 2 2
2 2 4 2




So the likelihood function (2) in this example is exactly (1).
Even for this simple case, the problem is highly non-trivial and remains sur-
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prisingly difficult. We know that the global maxima must exist, as the region of the
parameters is closed. By using EM algorithm or Newton-Raphson method and start-
ing from suitable points, one can find some local maxima of the likelihood function.
However, the global maximum property is not guaranteed.
Our paper is organized as follows. We first derive some general properties for
optimal solutions in Section A.2, then we prove the conjecture in Section A.3. In
Section A.4, we make some comments on why Gröbner basis technique does not work
efficiently, and suggest several new conjectures in more general cases.
A.2 General Properties
We focus on general n× n matrices P = (pij) in this section. For convenience
we scale each entry of P by n2 so the entries sum to n2, and take square root of the















pij ≥ 0, 1 ≤ i, j ≤ n.
Suppose P = (pij)n×n is a global maximum of L(P ). Apparently P cannot be the




1 . . . 1
...
...





as we have many other matrices (for instance, the resulting matrix by setting s =
2, t = 1 for the matrix in Conjecture 12 and then scaling by n2) with larger likelihood
value.
Since the function (3) is a continuous function in pij’s, if one of the entries of
P approaches 0, the product has to approach 0 too, as the other entries are bounded
by n2. Hence the optimal solutions must occur in interior points and we don’t need
to worry about the boundary where some pij = 0.
In the following discussion, we assume that P 6= J and all its entries are
positive. We show that P must have certain symmetry properties.













n with equality if and only
if si = n for all i. Let p̄ij =
n
si















· L(P ) ≥ L(P )
with equality if and only if si = n for all i. Since P is a global maximum, L(P̄ ) ≤
L(P ). Therefore each row sum equals n. Similarly, each column sum equals n as well.

We shall express P in a form that involves fewer variables and has no rank
constraint. Since P has rank at most two, by singular value decomposition theorem,
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for some nonnegative numbers σ1 and σ2. By Proposition 1, P has equal row and
column sums, so P has the vectors (1, 1, . . . , 1) and (1, 1, . . . , 1)t as its left and right
eigenvectors both with eigenvalue 1. Hence we may assume that σ1 = 1 and u1 =
v1 = (1, 1, . . . , 1)
t. Let v2 = (a1, a2, . . . , an)
t and σ2u2 = (b1, b2, . . . , bn)
t. Then P has
the form








(a1, a2, . . . , an) =


1 + a1b1 · · · 1 + anb1
... 1 + aibj
...














bi = 0. (4)
We have transformed the original problem to the following optimization prob-
lem:
Maximize: l(P ) = 2
n∑
i=1




Subject to: equation (4) and 1 + aibj > 0, 1 ≤ i, j ≤ n.
The Lagrangian function would be





































ai = 0, 1 ≤ j ≤ n. (6)
By Lemma 1, for an optimal solution P , its row sums and column sums must
be all equal to n. This means that
n∑
i=1




bi = 0. (8)
Plugging (7) and (8) into (5) and (6) respectively, we obtain the following lemma.

















= 0, 1 ≤ j ≤ n. (10)
Doing some simple algebra yields


















= n + 1, 1 ≤ j ≤ n. (12)







at both sides, we
can get (11). 
The 2n equations derived by clearing denominators of the equations in Lemma
2 or Corollary 3 along with equations (7) and (8) form a system S of 2n+ 2 polyno-
mial equations with 2n unknowns, whose solution contains all global maxima. From
computational view point we may solve S by brute force, like utilizing Gröbner basis
method, and then compare the local extrema to achieve the global maximum. How-
ever current symbolic computation softwares like Magma, Maple, Singular and so on
are still infeasible to compute a Gröbner basis for n = 4 by using the computers
available to us.
Our strategy below is to prove that P should have high symmetry: firstly ai’s
and bi’s are in the same order: if ai > aj > 0, then bi > bj > 0 correspondingly
(Lemma 4 and 5). For the case n = 4 once we force a1 = b1 by scaling, we can
eventually prove ai = bi for all other i’s (Lemma 7 and 9). With 4 ai’s remaining, we
prove that the ai’s with the same signs must be identical. Finally one can solve the
system by hand. Note that in [2] they derived results similar to Lemmas 4 and 5, but
our approach is fairly different.
Lemma 4 For every i,
1. ai = 0 if and only if bi = 0, and
2. ai > 0 if and only if bi > 0.
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Proof. (1) Plugging in ai = 0 to the equation (9), we have
n∑
j=1
bj +bi = 0, thus bi = 0.
Similarly, if bi = 0 then ai = 0.
(2) Note that g(x) = 1
x


























so aibi ≥ 0. We conclude that ai > 0 if and only if bi > 0. 
Lemma 5 For i and j,
1. ai = aj if and only if bi = bj, and
2. ai > aj if and only if bi > bj.






















, so ai = aj . Similarly, using (9), we have that if ai = aj then
bi = bj .
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(2) Switch bi, bj in P to form a new matrix P̄ . Then we should have L(P ) ≥ L(P̄ ).
Note that
L(P ) − L(P̄ ) = C1 · ((1 + aibi)
2(1 + aibj)(1 + ajbi)(1 + ajbj)
2
−(1 + aibj)
2(1 + aibi)(1 + ajbj)(1 + ajbi)
2)
= C2 · ((1 + aibi)(1 + ajbj) − (1 + aibj)(1 + ajbi))
= C2 · (aibi + ajbj − aibj − ajbi)
= C2 · (ai − aj)(bi − bj)
where C1, C2 are products of some entries of P , so C1, C2 are positive. Thus (ai −
aj)(bi − bj) ≥ 0. Note that ai = aj if and only if bi = bj by part(1), we conclude that
ai > aj if and only if bi > bj . 
A.3 Proof for the conjecture
We complete the proof for the conjecture in this section. From now on we focus
on the case when n = 4. By Lemma 5, we can always assume a1 ≥ a2 ≥ a3 ≥ a4 and










(b1, b2, b3, b4)









bi = 1 + aibj for any i and j, so we may always assume a1 = b1. Thus
P can be expressed as the form


1 + a21 1 + a2a1 1 + a3a1 1 + a4a1
1 + a1b2 1 + a2b2 1 + a3b2 1 + a4b2
1 + a1b3 1 + a2b3 1 + a3b3 1 + a4b3





If a2 ≤ 0, we then replace (a1, a2, a3, a4) in P by (−a4,−a3,−a2,−a1) and
(b1, b2, b3, b4)
t by (−b4,−b3,−b2,−b1)
t. The new matrix with −a4 ≥ −a3 ≥ 0 has the
same likelihood function as P . Thus we may assume a1 ≥ a2 ≥ 0. Without loss of
generality, we may make the following assumption.
Assumption 6 We can always assume the following
1. a1 ≥ a2 ≥ a3 ≥ a4 and b1 ≥ b2 ≥ b3 ≥ b4,
2. a1 = b1 > 0, and
3. a1 ≥ a2 ≥ 0.
The results in the rest of this section are all based on Assumption 6. Our first
goal is to prove a2 = b2.
Lemma 7 a2 = b2.
Proof. If one of a2, b2 is 0, then a2 = b2 = 0 by Lemma 4. We assume that both
a2, b2 are nonzero.














a21 + a2a1 + a3a1 + a4a1 = 0.
From above two equations we get
a3a1 · a4a1 = f1(a1a1, a1a2) (14)
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where f1 is a bivariate function in x, y defined as
f1(x, y) =





+ x+ y − 1.














a1b2 + a2b2 + a3b2 + a4b2 = 0,
we get
a3b2 · a4b2 = f1(a2b2, a1b2). (15)









Normalizing (16) we can derive a trivariate polynomial equation, say
f2(a1, a2, b2) = 0. (17)










One can see that equation (18) is obtainable by switching a2 with b2 in equation (16).
Thus we have
f2(a1, b2, a2) = 0. (19)
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Subtracting (19) from (17) yields
f2(a1, a2, b2) − f2(a1, b2, a2) = 0.
Since we only switched a2 and b2 in polynomial f2, there must be a factor a2 − b2 for
f2(a1, a2, b2) − f2(a1, b2, a2), say
(a2 − b2)f3(a1, a2, b2) = 0, (20)
where

























2 − 3a1 − b2)a2




1 − 3a1b2 − 2.
Thus a2 = b2 if f3(a1, a2, b2) 6= 0. This is true because we have some bounds
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for a21, a1a2, a1b2 as presented in Lemma 8 below, which can be applied to get

























2 − 3a1 − b2)a2






































































Proof.(1) Let Ai = 1 + a1ai for i = 1, . . . , 4, then
4∑
i=1
Ai = 4, A1 ≥ A2 ≥ 1,
























































4 − A1 − A2
,








(4 − A1 −A2)2
.
Note that A1 ≥ A2 ≥ 1, thus 4−A1−A2 ≤ 2 and
∂g(A2)
∂A2
≥ 0. Therefore g(A2) ≥ g(1)



























We get 2A21 − 5A1 + 3 ≤ 0, i.e. 1 ≤ A1 ≤
3
2




(2) Assume A2 = 1 + a1a2 >
6
5
































,∞). Note that A1 > 0 and A1 =
1 + a21 ≤
3
2





, which contradicts with A1 ≥ A2. Thus A2 ≤
6
5





(3) This result is followed by letting A1 = 1 + a
2
1 and Ai = 1 + a1bi for i ≥ 2.
The above proofs in part (1) and (2) remain good. 
Lemma 9 ai = bi for i = 3, 4.

















By the above two equations, since A3 ≥ A4, we can derive explicit expression for
A3, A4 in the variables A1, A2, say A3 = h1(A1, A2) and A4 = h2(A1, A2). If we let
Bi = 1 + a1bi, we can get B3 = h1(B1, B2) and B4 = h2(B1, B2) in a similar manner.
Note that A1 = B1 and A2 = 1 + a2b1 = 1 + b2a1 = B2, we deduce that Ai = Bi for
i = 3, 4. Since a1 = b1 > 0, ai = bi for i = 3, 4. 




1 + a21 1 + a2a1 1 + a3a1 1 + a4a1
1 + a1a2 1 + a
2
2 1 + a3a2 1 + a4a2
1 + a1a3 1 + a2a3 1 + a
2
3 1 + a4a3








ai = 0. (22)
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With (22) and (23), we claim that

















− 5 = 0.
Normalizing F (x) yields a polynomial (the numerator) of degree 6 in x whose constant
is 0 and whose coefficient of the term x is
4∑
i=1
ai = 0. So a1, a2, a3, a4, 0, 0 are all
the zeros of F (x). Suppose there exists consecutive i, j such that ai > aj > 0 (or















F (x) = −∞.




), say a0. Then a0 < −
1
ai
(or a0 > −
1
aj
respectively), i.e. 1 + aia0 < 0 (or 1 + aja0 < 0 respectively). Since a0 6= 0, x0 must
be one of ak, k = 1, . . . , 4. Thus 1 + aia0 (or 1 + aja0, respectively) is an entry in
matrix P , contradicting the fact that each entry of P is positive. Therefore if i, j are
consecutive and aiaj > 0, we must have ai = aj . Hence aiaj > 0 implies ai = aj for
any i, j. 
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With Lemma 10 it is handy to solve the system (23). Under Assumption
(6) there are only 4 possible patterns of signs for (a1, a2, a3, a4). If the signs are
(+,+,+,−), then a1 = a2 = a3 = −
1
3
a4. Substitute this to any equation in (23)
yields a1 = a2 = a3 =
1√
15
and a4 = −
3√
15


















































































































And when the signs are (+, 0, 0,−), a1 =
1√
3








1 1 1 1








The matrices obtaining local maximum of the likelihood function must be
among the matrices above. We conclude that matrix P2 obtains the global maximum.









3 3 2 2
3 3 2 2
2 2 3 3




A.4 Some comments on general cases and discussion
A natural question arises here is that why Gröbner basis technique [6], the most
powerful tool for solving systems of polynomial equations, does not work efficiently
for this particular problem. We get a polynomial (a2−b2)f3(a1, a2, b2) in the proof for
Lemma (7). Our approach is to justify the factor f3(a1, a2, b2), a trivariate polynomial
with 17 terms, is nonzero by applying some bounds from Lemma 8, so that we can
derive the simplest equation a2 − b2 = 0. In the proof we used the fact that we
are looking only for real solutions. However, a Gröbner basis encodes both real and
complex solutions. It is possible that f3(a1, a2, b2) is zero for some complex solutions.
The locus of all solutions may be much more complicated than that of real solutions,
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hence the Gröbner basis is much more time consuming to compute.
The limitation of our work is that the arguments in the last section only work
for n = 4. For n > 4 we are still lack of an efficient method. However, our methods
can still be applied to general likelihood functions. In the following, we illustrate for
a few examples.
Conjecture 11 For given 0 < t < s where t, s are two integers, among the set of all






















































But the bounds in Lemma 8 involve the fraction s
t
and become complicated. A similar
equation to (20) can be derived, but the nonzero factor is difficult to claim. Hopefully
we may also prove a2 = b2. Then a3 = b3 and a4 = b4 can be derived in a similar
manner to Lemma 9. So does Lemma 10. Finally we can find 4 local extrema and
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need only compare them to obtain the global maximum. In the case when the signs
of (a1, a2, a3, a4) are (+,+,+,−), we have the equation
a21((3s+ 9t)a
2
























































































One can prove that L(P1) < L(P2) by some calculus technique, for example,
taking the partial derivative of L(P1)
L(P2)
with respect to s. In similar approaches one can
also show that L(P3) < L(P2) and L(P4) < L(P2) where P3, P4 are the corresponding
matrices for the cases when signs are (+,+, 0,−) and (+, 0, 0,−) respectively. Thus
the matrix in (25) is a global maximum.
More generally, let (u)l1×l2 be a block matrix with every entry being u where
l1 × l2 ∈ N2 and u > 0.
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Conjecture 12 Let n ≥ 2 and 0 < t < s. Then the matrix
P =
1



























is a global maximum for the likelihood function L(P) in (24).











































is a global maximum for the likelihood function L(P) in (24).
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Appendix B Computing Irreducible Decomposition
of Monomial Ideals
Abstract
The paper presents two algorithms for finding irreducible decomposition of
monomial ideals. The first one is recursive, derived from staircase structures of mono-
mial ideals. This algorithm has a good performance for highly non-generic monomial
ideals. The second one is an incremental algorithm, which computes decompositions
of ideals by adding one generator at a time. Our analysis shows that the second
algorithm is more efficient than the first one for generic monomial ideals. Further-
more, the time complexity of the second algorithm is at most O(n2pℓ) where n is the
number of variables, p is the number of minimal generators and ℓ is the number of
irreducible components. Another novelty of the second algorithm is that, for generic
monomial ideals, the intermediate storage is always bounded by the final output size
which may be exponential in the input size.
B.1 Introduction
Monomial ideals provide ubiquitous links between combinatorics and commu-
tative algebra [24, 16]. Though simple they carry plentiful algebraic and geometric
information of general ideals. Our interest in monomial ideals is motivated by a paper
of [9], where they studied the connection between the structure of monomial basis
and the geometric structure of the solution sets of zero-dimensional polynomial ideals.
Irreducible decomposition of monomial ideals is a basic computational problem and it
finds applications in several areas, ranging from pure mathematics to computational
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biology, see for example [12] for computing integer programming gaps, [3] for comput-
ing tropical convex hulls, [22] for finding the joins and secant varieties of monomial
ideals, [2] for partition of a simplicial complex, [19] for solving the Frobenius problem,
and [13] for modeling gene networks.
We are interested in efficient algorithms for computing irreducible decomposi-
tion of monomial ideals. There are a variety of algorithms available in the literature.
The so-called splitting algorithm: Algorithm 3.1.2 in [23] is not efficient on large scale
monomial ideals. [17] gives two algorithms: one is based on Alexander duality [14],
and the other is based on Scarf complex [4]. [18] improves the Scarf complex method
by a factor of up to more than 1000. Recently, [20] proposed several slicing algorithms
based on various strategies.
Our goals in this paper are to study the structure of monomial ideals and
present two new algorithms for irreducible decomposition. We first observe some
staircase structural properties of monomial bases in Section B.4. The recursive algo-
rithm presented in Section B.5 is based on these properties, which allow decomposi-
tion of monomial ideals recursively from lower to higher dimensions. This algorithm
was presented as posters in ISSAC 2005 and in the workshop on Algorithms in Al-
gebraic Geometry at IMA in 2006. Our algorithm was recently generalized by [20]
where several cutting strategies were developed and our algorithm corresponds to
the minimum strategy there. Also, the computational experiments there shows that
our algorithm has good performance for most cases, especially for highly non-generic
monomial ideals.
Our second algorithm is presented in Section B.6. It can be viewed as an
improved Alexander dual method ([14, 17]). It is incremental based on some distri-
bution rules for “+” and “∩” operations of monomial ideals. We maintain an output
list of irreducible components, and at each step we add one generator and update the
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output list. In [17], there is no specific criterion for selecting candidates that need to
be updated, and the updating process is inefficient too. Our algorithm avoids these
two deficiencies. Our analysis in Section B.7 shows that the second algorithm works
more efficiently than the first algorithm for generic monomial ideals. We prove that,
for generic monomial ideals, the intermediate storage size (ie. number of irreducible
components at each stage) is always bounded by the final output size, provided that
the generators are added in lex order. This enables us to show that the time complex-
ity of the second algorithm is at most O(n2pℓ) where n is the number of variables, p
is the number of minimal generators and ℓ is the number of irreducible components.
In Section B.2, we present some notations and introductory materials on mono-
mial ideals. In Section B.3 we discuss tree representations and operations of monomial
ideals.
B.2 Monomial Ideals
We refer the reader to the books of [5] for background in algebraic geometry
and commutative algebra, and to the monograph [16] for monomial ideals and their
combinatorial properties.
Let K be a field and K[X], the polynomial ring over K in n indeterminates
X = x1, . . . , xn. For a vector α = (a1, . . . , an) ∈ Nn, where N = {0, 1, 2, . . .} denotes
the set of nonnegative integers, we set
Xα = xa11 . . . x
an
n ,
which is called a monomial. Thus monomials in n variables are in 1 − 1 correspon-
dence with vectors in Nn. Suppose α = (a1, . . . , an) and β = (b1, . . . , bn) are two
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vectors in Nn, we say
α ≤ β if aj ≤ bj for all 1 ≤ j ≤ n.
This defines a partial order on Nn, which corresponds to division order for monomials
since xα|xβ if and only if α ≤ β. We say
α < β if α ≤ β but α 6= β.
Also we define
α ≺ β if aj < bj for all 1 ≤ j ≤ n.
Then α ⊀ β means that aj ≥ bj for at least one j.
An ideal I ⊂ K[X] is called a monomial ideal if it is generated by monomials.
Dickson’s Lemma states that every monomial ideal in K[X] has a unique minimal set
of monomial generators, and this set is finite. Denote this set to be Min(I), that is,
Min(I) = {Xα ∈ I : there is no Xβ ∈ I such that β < α}.
A monomial ideal I is called Artinian if I contains a power of each variable,
or equivalently, if the quotient ring K[X]/I has finite dimension as vector space over
K. For convenience of notations, we define
x∞i = 0, 1 ≤ i ≤ n.
By adding infinity power of variables if necessary, a non-Artinian monomial ideal can
be treated like an Artinian monomial ideal. For example, I = 〈x2y3〉 = 〈x∞, x2y3, y∞〉.
Instead of adding infinity powers, we can also add powers xcii where ci is a sufficiently
98
large integer, say larger than the largest degree of xi in all the monomials in Min(I).
Then the irreducible components of the original ideal are in 1-1 correspondence to
those of the modified Artinian ideal; See Exercise 5.8 in [16] or Proposition 3 in [20].
In our algorithms belows, we will use infinity powers, but in the proofs of all the
results, we will use powers xcii .
An ideal J ⊂ K[X] is called irreducible if it can not be expressed as the
intersection of two strictly larger ideals in K[X]. That is, J = J1 ∩ J2 implies that
J = J1 or J = J2. A monomial ideal I is irreducible if and only if I is of the form
mβ = 〈xb11 , . . . , x
bn
n 〉
for some vector β = (b1, . . . , bn) ∈ N
n
where N = N ∪ {∞} \ {0}. Thus irreducible
monomial ideals are in 1-1 correspondence with β ∈ N
n
.
An irreducible decomposition of a monomial ideal I is an expression of the
form
I = mβ1 ∩ · · · ∩mβr (26)
where β1, . . . , βr ∈ N
n
. Since the polynomial ring K[X] is Noetherian, every ideal
can be written as irredundant intersection of irreducible ideals. Such an intersection
is not unique for a general ideal, but unique for a monomial ideal. We say that the
irreducible decomposition (26) is irredundant if none of the components can be
dropped from the right hand side. If (26) is irredundant, then the ideals mβ1 , . . . , mβr
are called irreducible components of I. We denote by Irr(I) the set of exponents
of irreducible components of I, that is,
Irr(I) = {β1, . . . , βr}.
99





Note that, for two vectors α and β,
Xα ∈ mβ if and only if α ⊀ β,
and
mα ⊂ mβ if and only if β ≤ α.
A monomial ideal I is called generic if no variable xi appears with the same
non-zero exponent in two distinct minimal generators of I. This definition comes
from [4]. For example,
I1 = 〈x
4, y4, x3y2z, xy3z2, x2yz3〉
is generic, but
I2 = 〈x
4, y4, x3y2z2, xy3z2, x2yz3〉
is non-generic, as z2 appears in two generators. Loosely speaking, we can say I2 is
nearly generic, but
I3 = 〈xy, yz, xz, z
2〉
is highly non-generic. Previous algorithms [17, 18] behave very different for generic
monomial ideals and highly non-generic monomial ideals. For example, the Scarf
complex method works more efficient when dealing with generic monomial ideals
[17].
In the following sections, we always assume that we are given the minimal
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generating set of a monomial ideal. Though our algorithms work for monomial ideals
given by an arbitrary set of generators, it will be more efficient if the generators are
made minimal first.
B.3 Tree Representation and Operations
Note that monomials are represented by vectors in Nn and irreducible compo-
nents are represented by vectors in N
n
. To efficiently represent a collect of vectors,
we use a tree structure. This is used in [9, 17]. This data structure is also widely
used in computer science, where it is called a trie.
Tree representation. First we want to define the orderings on Nn or N
n
. Suppose
α = (a1, . . . , an) and β = (b1, . . . , bn) are two vectors in Nn or N
n
, and the variable
ordering is x1 < · · · < xn in K[X]. We say α <lex β if aj = bj for k + 1 ≤ j ≤ n, but
ak < bk for some 1 ≤ k ≤ n.
Next, suppose S ⊂ Nn is a set of vectors corresponding to the generators of a
monomial ideal I ⊂ K[X]. We represent S as a rooted tree T of height n in a natural
way. The tree should have |S| leaves and the unique path of the tree from the root
to a leaf represents a vector in S. Precisely, to represent a vector α = (a1, . . . , an),
we label all the nodes except the root of the path simply by an, . . . , a1 in the order
from the root to the leaf. We regard the root as being at height 0. For two vectors
α = (a1, . . . , an) and β = (b1, . . . , bn), if aj = bj for k + 1 ≤ j ≤ n but ak 6= bk, then
α and β share their corresponding path until height n− k. After that their children
are listed in increasing order with respect to their coordinates. Figure 1 is the tree




0 4 2 3 1




Figure 1: An example of tree representation.
The tree representation for a set of irreducible components could be con-
structed in a similar manner.
To perform the operations on sets of vectors, we need only perform on trees.
We need three basic tree operations: Merge,MinMerge and MaxMerge.
Merge. Given q rooted trees T1, . . . , Tq with the same height, merge them to form
one rooted tree with the same height. Here we simply put the paths from all the trees
together with repetition ignored (actually no repeated paths occur in our algorithms).
We stress that no reduction work is performed under this operation.
MinMerge. We use MinMerge(T1, . . . , Tq) to represent the set of minimal elements
in Merge(T1, . . . , Tq). For two vectors α, β in Merge(T1, . . . , Tq), if α ≤ β, ie. x
α|xβ,
then the path for β should be removed in this operation. The purpose is to find the
minimal generating set for the ideal I1 + · · · + Iq where Ti is the tree representation
for Ii.
MaxMerge. Similarly, the set of maximal elements in Merge(T1, . . . , Tq) is repre-
sented by MaxMerge(T1, . . . , Tq). If α ≤ β, ie. m
β ⊂ mα, then the path for α should
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be removed in this operation. Hence, if Ti represents the set of irreducible compo-
nents of Ii, 1 ≤ i ≤ q, then MaxMerge(T1, . . . , Tq) represents the the set of irreducible
components of the ideal I1 ∩ · · · ∩ Iq.
B.4 Structure Properties of Monomial Bases
In the results and their proofs below, we explicitly assume that all the ideals
are Artinian, adding large powers xNi if necessary where N is an integer, though
infinity powers will be used in the Algorithms and Examples.
The monomial basis B(I) for a monomial ideal I is defined as
B(I) = {γ ∈ Nn : Xγ /∈ I},
which form a linear basis for the quotient ring K[X]/I over K. Thus, for γ ∈ Nn,
γ ∈ B(I) if and only if α  γ for every α ∈ Min(I). Note that B(I) is a δ-set, that is,
if γ ∈ B(I) and µ ≤ γ, then µ ∈ B(I). The next lemma characterizes B(I) in terms
of Irr(I).
Lemma 14 For γ ∈ Nn, γ ∈ B(I) if and only if γ ≺ β for some β ∈ Irr(I).
Proof. Since I = ∩
β∈Irr(I)m
β, we have Xγ ∈ I if and only if Xγ ∈ mβ, ie., γ ⊀ β, for
each β ∈ Irr(I). Hence Xγ /∈ I if and only if γ ≺ β for some β ∈ Irr(I), as desired. 
We now want to express Irr(I) in terms of B(I). Since I is Artinian, for
β = (b1, . . . , bn) ∈ Irr(I), we have bi > 0 for 1 ≤ i ≤ n. Define
β ⊖ 1 = (b1 − 1, b2 − 1, . . . , bn − 1).
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Lemma 14 implies that, for each β ∈ Irr(I), we have β ⊖ 1 ∈ B(I).
A vector γ ∈ Nn is called maximal in B(I) if
γ ∈ B(I) and there is no µ ∈ B(I) such that µ > γ.
Lemma 15 For any vector β ∈ Nn, β ∈ Irr(I) if and only if β ⊖ 1 is maximal in
B(I).
Proof. By Lemma 14, β ⊖ 1 ∈ B(I) if and only if there is α ∈ Irr(I) such that
β⊖1 ≺ α. Notice that α⊖1 ∈ B(I) and β⊖1 ≺ α is equivalent to say β⊖1 ≤ α⊖1.










Figure 2: An example of staircase diagram.
The staircase diagram will help us visualize the structural properties of mono-
mial ideals. For example, Figure 2 is the staircase diagram for the monomial ideal
I = 〈x4, y4, x3y2z2, xy3z2, x2yz3〉. In this figure the gray points are in 1-1 correspon-
dence with the minimal generators, while the white points are in 1-1 correspondence
with the irreducible components of I. Geometrically, B(I) is exactly the set of interior
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integral points of the solid.
B.5 Recursive Algorithm




xa1 , xa2yb2, . . . , xap−1ybp−1, ybp
}
where a1 > · · · > ap−1 > 0, 0 < b2 < · · · < bp, and a1 or bp can be infinity. Then the
irreducible decomposition of I is
I = 〈xa1 , yb2〉 ∩ 〈xa2 , yb3〉 ∩ · · · ∩ 〈xap−2 , ybp−1〉 ∩ 〈xap−1 , ybp〉.
Our recursive algorithm is a generalization of the above observation to higher
dimensions. Let I ⊂ K[x1, . . . , xn] be a monomial ideal. Suppose all the distinct
degrees of xn in Min(I) are
0 = d0 < d1 < . . . < ds.
For example, in I = 〈x2y3〉 = 〈x∞, x2y3, y∞〉, the distinct degrees in y are d0 =
0, d1 = 3 and d3 = ∞. We collect the coefficients of m ∈ Min(I) as polynomials in
xn. Precisely, for 0 ≤ k ≤ s, let
Ik = 〈Coeffxn(m) : m ∈ Min(I) and degxn m ≤ dk〉 ⊆ K[x1, . . . , xn−1].
Then
I0 ( I1 ( · · · ( Is. (27)
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By (27), it follows that
B(I0) ) B(I1) ) · · · ) B(Is).
For the example with I = 〈x∞, x2y3, y∞〉, I0 = 〈x
∞〉 = {0}, I1 = 〈x
∞, x2〉 = 〈x2〉,
and I2 = 〈x
∞, x2, 1〉 = 〈1〉 = K[x].
We show how to read off the irreducible components of I from those of Ik’s,
which have one less variables. For any vector µ = (u1, . . . , un−1) ∈ Nn−1 and d ∈ N,
define
(µ, d) = (u1, . . . , un−1, d) ∈ N
n.
Lemma 16 For any µ ∈ Nn−1 and d ∈ N, (µ, d) ∈ B(I) if and only if there exists k,
where 1 ≤ k ≤ s, such that dk−1 ≤ d < dk and µ ∈ B(Ik−1).
Proof. (µ, d) ∈ B(I) if and only if there is no m ∈ Min(I) such that m|X(µ,d). As
dk−1 ≤ d < dk, we only need to see that there is no m ∈ Min(I) with degxn m ≤ dk−1.
But this is equivalent to requiring that µ ∈ B(Ik−1). 
For a set of vectors U and an integer d, define
U ⊗ d = {(u, d) : u ∈ U}.






⊗ dk, which is a disjoint union.
Proof. Assume µ ∈ Irr(Ik−1) \ Irr(Ik). We first show that (µ, dk) ⊖ 1 ∈ B(I)
and µ ⊖ 1 ∈ B(Ik−1) \ B(Ik). Since µ ∈ Irr(Ik−1), we have µ ⊖ 1 ∈ B(Ik−1), so
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(µ, dk) ⊖ 1 = (µ ⊖ 1, dk − 1) ∈ B(I) by Lemma 16. Also, by Lemma 15, there is no
γ ∈ B(Ik−1) such that γ > µ ⊖ 1, in particular no γ ∈ B(Ik) such that γ > µ ⊖ 1,
as B(Ik) ⊂ B(Ik−1). Thus µ⊖ 1 /∈ B(Ik), otherwise we would have µ ∈ Irr(Ik) which
contradicts the assumption on µ.
For (µ, dk) ∈ Irr(I), we need to prove that (µ, dk) ⊖ 1 is maximal in B(I).
Assume otherwise, say (γ, d) ∈ B(I) and (γ, d) > (µ, dk) ⊖ 1. Then d ≥ dk or
d = dk −1. If d ≥ dk, then γ ∈ B(Ij) where k ≤ j ≤ s by Lemma 16. Since γ ≥ µ⊖1
and B(Ik) is a δ-set, γ ∈ B(Ij) implies µ ⊖ 1 ∈ B(Ij) ⊂ B(Ik) too, a contradiction.
If d = dk − 1, then γ > µ ⊖ 1. Note that (γ, dk − 1) ∈ B(I) implies γ ∈ B(Ik−1) by
Lemma 16. However, µ ∈ Irr(Ik−1) so there is no γ ∈ B(Ik−1) such that γ > µ⊖ 1, a
contradiction. Hence such (γ, d) does not exist. Consequently, (µ, dk) ∈ Irr(I).
Conversely, assume (µ, d) ∈ Irr(I), we need to prove that there exist some
1 ≤ k ≤ s such that d = dk and µ ∈ Irr(Ik−1) \ Irr(Ik). By Lemma 15, (µ, d) ∈ Irr(I)
implies
(µ, d) ⊖ 1 ∈ B(I), (28)
and there is no (γ, l) ∈ B(I) such that
(γ, l) > (µ, d) ⊖ 1. (29)
By Lemma 16, (28) implies there exists k such that µ⊖ 1 ∈ B(Ik−1), and
dk−1 ≤ d− 1 < dk. (30)
By Lemma 16 again, (µ ⊖ 1, dk − 1) ∈ B(I). Then (29) and (30) imply that d = dk.
(29) and (30) also imply that there is no γ such that γ ∈ B(Ik−1) and γ > µ⊖ 1, so
µ ∈ Irr(Ik−1).
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It remains to prove µ /∈ Irr(Ik). Assume µ ∈ Irr(Ik). Then µ ⊖ 1 ∈ B(Ik).
By Lemma 16, (µ ⊖ 1, dk) ∈ B(I) and (µ ⊖ 1, dk) > (µ, dk) ⊖ 1, contradicting to
(µ, dk) ∈ Irr(I). Thus µ ∈ Irr(Ik−1) \ Irr(Ik). 
Theorem 17 gives us the following recursive algorithm for finding irreducible
decomposition of monomial ideals. Suppose we are given I = 〈Xα1 , . . . , Xαp〉 and
fixed variable order x1 < · · · < xn. We encode the set {α1, . . . , αp} as a tree T of
height n. Our algorithm Irr(T ) takes T as input and produce Irr(I) as output. That
is, Irr(I) = Irr(T ).
Recursive Algorithm: Irr(T )
Input: T , a tree encoding Min(I)
Output: S, a set (or a tree) representing Irr(I)
Step 1. Start at the root of T . If the height of T is 1, then T consists of a few leaves;
let d be the largest label on these leaves and let S := {d}.
Return S (and stop the algorithm).
Step 2. Now assume T has height at least two. Set S := { }.
Step 3. Suppose d0 < d1 < · · · < ds are the labels of the children under the root of T ,
and let Tk be the subtree extending from dk, 0 ≤ k ≤ s.
Note that the root of Tk is the node labeled by dk, but now unlabeled.
Find V0 := Irr(T0) by recursive call of this algorithm.
For k from 1 to s do
3.1. Find Tk := MinMerge(Tk−1, Tk), and delete Tk−1.
3.2. Find Vk := Irr(Tk) by recursive call of this algorithm.
3.3. Find V := Vk−1 \ Vk, delete Vk−1, and S := Merge(S, V ⊗ dk).
Step 4. Return (S).
108
Example 18 We end this section by demonstrating how the algorithm is used to
decompose the ideal I = 〈x4, y4, x3y2z2, xy3z2, x2yz3〉. First represent the monomials
as a tree with variable order x < y < z, where Tk’s are the subtrees extending from
the node with label dk, k = 0, 1, 2, 3.
root
0 2 3 ∞
0 4 2 3 1






d0 d1 d2 d3
T0 T1 T2 T3
Figure 3: Tree representation.
root
0 2 3 ∞
0 4 2 3 1
















d0 d1 d2 d3
T0 T1 T2 T3
Figure 4: MinMerge step.
Figure 4-5 show the process of finding the irredundant irreducible decomposition
of I. For each Tk, inductively MinMerge the subtrees from left to right, corresponding
to Step 3.1 in the Recursive algorithm. See Figure 4. In Figure 5 we call the procedure
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root
0 2 3 ∞
0 4 2 3 1
















d0 d1 d2 d3
X X X × X X X
Irr(T0) Irr(T1) Irr(T2) Irr(T3)
Figure 5: Shifting step.
Irr( ) for each Tk to compute Irr(Tk), corresponding to Step 3.2. Since the height of Tk
is 2, we bind each leaf that is not in the most-right side of Tk with the node of height
2 on the next path - just do the shifting in adjacent paths, see Figure 5. Finally we
find the paths in Irr(Tk−1) that are not in Irr(Tk). The one with a mark × in Irr(Tk)
is discarded. Then bind the resulting paths with dk. The irreducible components can
be read from the last figure:
Irr(I) = {(4, 4, 2), (4, 2, 3), (3, 3, 3), (4, 1,∞), (2, 3,∞), (1, 4,∞)}.
B.6 Incremental Algorithm
In this section we shall present an incremental algorithm based on the idea of
adding one generator at a time. This algorithm can be viewed as an improvement
of Alexander Dual method ([14, 17]). We maintain an output list of irreducible
components, and at each step we use a new generator to update the output list. In
[17], it is not clear how to select good candidates that need to be updated, and the
updating process there is also inefficient. Our algorithm avoids these two deficiencies.
We establish some rules that help us to exclude many unnecessary comparisons.
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Monomial ideal are much simpler than general ideals. The next theorem tells
us that monomial ideals satisfy distribution rules for the operations “+” and “∩”.
These rules may not be true for general ideals.
Theorem 19 (Distribution Rules) Let I1, . . . , It, J be any monomial ideals in K[X].
Then
(a) (I1 + . . .+ It) ∩ J = I1 ∩ J + . . .+ It ∩ J , and
(b) (I1 ∩ . . . ∩ It) + J = (I1 + J) ∩ . . . ∩ (It + J).
Proof. By induction, we just need to prove the case for t = 2. Note that (b) follows
form (a), as
(I1 + J) ∩ (I2 + J) = I1 ∩ (I2 + J) + J ∩ (I2 + J)
= I1 ∩ I2 + I1 ∩ J + J ∩ I2 + J
= I1 ∩ I2 + J.
To prove (a) for the case t = 2, suppose h is a generator for (I1 +I2)∩J . Then h must
be in (I1 + I2) and J . Since (I1 + I2) ∩ J is also a monomial ideal, h is a monomial.
The fact that h ∈ I1 + I2 implies that h is in either I1 or I2. Hence h is in I1 ∩ J
or in I2 ∩ J , so h ∈ I1 ∩ J + I2 ∩ J . Going backward yields the proof for the other
direction. 
Theorem 19 gives us an incremental algorithm for irreducible decomposition
of monomial ideals. Precisely, we have the following situation at each incremental
step: Given the irreducible decomposition Irr(I) of an arbitrary ideal I and a new
monomial Xα where α = (a1, . . . , an) ∈ Nn, we want to decompose Ĩ = I + 〈Xα〉. By
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We need to see how to decompose each ideal on the right hand side of (31) and how
to get rid of redundant components. We partition Irr(I) into two disjoint sets:
T α1 = {β ∈ Irr(I) : α ⊀ β}, and (32)
T α2 = {β ∈ Irr(I) : α ≺ β}. (33)
Note that if Xα ∈ I then T α2 = φ. For each β ∈ T
α
1 , we have X
α ∈ mβ, thus
mβ + 〈Xα〉 = mβ . (34)
For each β ∈ T α2 , we have X







By the distribution rule (b), we have










β(α,j) = (b1, . . . , bj−1, aj , bj+1, . . . , bn), 1 ≤ j ≤ n.
112
Since α ≺ β, we have aj < bj for all 1 ≤ j ≤ n. Hence m
β + 〈x
aj
j 〉 = m
β(α,j) , and









T α1 , {β
(α,j) : β ∈ T α2 and 1 ≤ j ≤ n}
)
. (36)
It remains to see which of the components in the right hand side of the above
expression belong to Irr(Ĩ), so others are redundant.
Lemma 20 T α1 ⊂ Irr(Ĩ).
Proof. Let β1 ∈ T
α
1 . By equation (36) if β1 /∈ Irr(Ĩ), then there exists some β2 ∈ T
α
2
such that β1 is maxmergeed by β
(α,j)
2 for some j, ie. β1 ≤ β
(α,j)





2 implies that β1 < β2, which contradicts with the fact that β1, β2 ∈ Irr(I).
Hence β1 ∈ Irr(Ĩ) as claimed. 
Lemma 20 shows that the elements in T α1 will be automatically in Irr(Ĩ). Now we
turn to the components β(α,j). For β ∈ T α2 , define
Mβ = {m ∈ Min(I) : m|X
β}. (37)
For m ∈ Mβ , if degxu m = bu, then we say m matches β in xu. It is possi-
ble that one monomial matches β in multiple variables. For example, with I =
〈x2, y2, z2, xy, xz, yz〉 and β = (1, 1, 2) ∈ Irr(I), the monomial xy matches β in x and
y. We say m matches β only in xu if degxu m = bu and degxk m < bk for all k 6= u.
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Lemma 21 For each β = (b1, . . . , bn) ∈ T
α
2 and each 1 ≤ u ≤ n, there exists m ∈Mβ
such that m matches β only in xu.
Proof. Note that a vector γ ∈ B(I) is maximal if and only if Xγ ·xu ∈ I for every u.
Since β ∈ Irr(I), β ⊖ 1 is maximal in B(I). Thus, for each 1 ≤ u ≤ n, Xβ⊖1 · xu ∈ I,
so there exists a monomial say m ∈ Min(I) such that m|Xβ⊖1 ·xu. Then degxk m < bk
for k 6= u. If degxu m < bu as well, then m|X
β⊖1, which implies that Xβ⊖1 ∈ I, a
contradiction. Therefore degxu m = bu. Note that X
β⊖1 · xu|X
β, so m ∈Mβ . 
For any set of monomials A ⊂ K[X], define max(A) be the exponent γ such
that Xγ = Lcm(A).
Lemma 22 max(Mβ) = β.
Proof. By the definition of Mβ, we know that max(Mβ) ≤ β. By Lemma 21 we have
max(Mβ) ≥ β. Thus max(Mβ) = β. 
For k 6= u, let
d(β, u, k) = min{degxu m : m ∈Mβ matching β only in xk}. (38)
Note that d(β, u, k) < bu. Define
d(β, u) = max
1≤k≤n,k 6=u
{d(β, u, k)}.
Lemma 23 For each β ∈ T α2 and 1 ≤ u ≤ n, β
(α,u) ∈ Irr(Ĩ) if and only if d(β, u) <
au.
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Proof. Suppose d(β, u) < au. We want to prove that β
(α,u) ∈ Irr(Ĩ). By Lemma
15, this is equivalent to proving that β(α,u) ⊖ 1 ∈ B(Ĩ) and is maximal. Assume
β(α,u) ⊖ 1 /∈ B(Ĩ). Then there exists m ∈ Min(I)∪ {Xα} such that m|Xβ
(α,u)⊖1. First
note that m 6= Xα because Xα can not divide Xβ
(α,u)⊖1. Thus m ∈ Min(I), which
implies Xβ
(α,u)⊖1 ∈ I. Since β(α,u) ⊖ 1 < β ⊖ 1, we have Xβ⊖1 ∈ I, contradicting
to β ∈ Irr(I). Hence β(α,u) ⊖ 1 ∈ B(Ĩ). We next need to prove that β(α,u) ⊖ 1 is
maximal in B(Ĩ), that is, Xβ
(α,u)⊖1 · xk ∈ Ĩ for every k. In the case for k = u,
we have Xα|Xβ
(α,u)⊖1 · xu. For any k 6= u, let m be any monomial in (38) such that
degxu m = d(β, u, k). Then degxu m = d(β, u, k) ≤ d(β, u) < au, hence m|X
β(α,u)⊖1 ·xk
as degxk m = bk and degxj m ≤ bj − 1 for j 6= u, k.
Conversely, suppose β(α,u) ∈ Irr(Ĩ). We want to prove that d(β, u) < au. We
know that β(α,u) ⊖ 1 is maximal in B(Ĩ). Thus Xβ
(α,u)⊖1 · xk ∈ Ĩ for every k. For any
k 6= u, suppose Xβ
(α,u)⊖1 · xk is divisible by m ∈ Min(I) ∪ {X
α}. Then
degxu m ≤ au − 1 < bu, degxj m ≤ bj − 1, j 6= u, k, (39)
and degxk m ≤ bk. As X
β(α,u)⊖1 ∈ B(Ĩ) ⊂ B(I), m can not divide Xβ
(α,u)⊖1. Hence
degxk m ≤ bk. So m matches β only in xk. Note that m 6= X
α, so m ∈ M and thus
m ∈ Mβ. It follows that d(β, u, k) ≤ au − 1 by (39). Therefore, d(β, u) < au as
desired. 
By the above lemma, for each β ∈ T α2 , we only need to find Mβ and d(β, u),
which will tell us whether β(α,u) ∈ Irr(Ĩ). This gives us the following incremental
algorithm.
Incremental algorithm
Input: M , a set of monomials in n variables x1, . . . , xn.
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Output: Irr(I), the irredundant irreducible components of the ideal I generated by M .
Step 1. Compute MinMerge(M) and sort it into the form:
MinMerge(M) = {xc11 , . . . , x
cn
n , X
α1, . . . , Xαp},
where ci can be ∞ and {X
α1 , . . . , Xαp} are sorted in lex order with variable
order x1 < . . . < xn. Set
T := {(a1, . . . , an)}.
Step 2. For each k from 1 to p do:
2.1. Set the temporal variables V = ∅ and α := αk.
2.2. For every β ∈ T with α ⊀ β do
V := V ∪ {β}.
2.3. For every β ∈ T with α ≺ β do,
• find Mβ as defined in (37);
• for 1 ≤ u ≤ n, compute d(β, u), and if d(β, u) < au then update
V := V ∪ {β(α,u)}.
2.4. Set T := V .
Step 3. Output T .
We next prove that there is a nice property of the above algorithm for generic
monomial ideals, that is, the size of T is always non-decreasing at each stage when a
new generator is added. This will allow us to bound the running time of the algorithm
in term of input and output sizes.
Theorem 24 Suppose I is generic and Min(I) = {xc11 , . . . , x
cn
n , X
α1 , . . . , Xαp} where
Xαk ’s are sorted in lex order with variable order x1 < . . . < xn. Let Î = 〈x
c1
1 , . . . , x
cn
n ,
Xα1 ,. . . , Xαp−1〉. Then |Irr(Î)| ≤ |Irr(I)|.




only monomial in Mβ that has degree in xn larger than an. Hence d(β, n) < an and
β(α,n) ∈ Irr(I). By the equation (36) and Lemma 20,
|Irr(I)| ≥ |T α1 | + |{β
(α,n) : β ∈ T α2 }| = |T
α
1 | + |T
α
2 | = |Irr(Î)|.

The reader might wonder whether a similar statement holds in non-generic case
as well. The answer is negative. Let I = 〈x3, y3, z2, w2, x2yz, xy2w〉 ⊂ K[x, y, z, w]
with lex order and x < y < z < w. Then
Irr(I) = {(3, 3, 1, 1), (2, 3, 2, 1), (3, 2, 1, 2), (3, 1, 2, 2), (2, 2, 2, 2), (1, 3, 2, 2)}.
By addingXα = xyzw, we can see β = (2, 2, 2, 2) ∈ T α2 . Note thatMβ = {x
2yz, xy2w, z2,
w2}. Since d(β, u) = 1 = au for u = 1, 2, 3, 4, no new β
(α,j) will be generated. Thus
the number of irreducible components decreases by 1 instead.
We find the irreducible components for the monomial ideal in Example 18
again by the flow of our incremental algorithm.
Example 25 Decompose
I = 〈x4, y4, x3y2z2, xy3z2, x2yz3〉.
Note: “X” means β(α,u) ∈ Irr(Ĩ) for corresponding β, α and u, while “×”
means not.
Step 1. M = {x4, y4, z∞, x3y2z2, xy3z2, x2yz3}. Set T := {(4, 4,∞)}.
Step 2. (i) For α = (3, 2, 2) do:
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2.1. V := φ.
2.2. Since α ≺ (4, 4,∞), V := φ.
2.3. Let β = (4, 4,∞). We find Mβ = {x
4, y4}.
So we have d{β, 1} = 0(X), d{β, 2} = 0(X) and d{β, 3} = 0(X).
Then V := {(3, 4,∞), (4, 2,∞), (4, 4, 2)}.
2.4. Let T := V .
(ii) For α = (1, 3, 2) do:
2.1. V := φ.
2.2. Update V by V := {(4, 4, 2), (4, 2,∞)}.
2.3. α ≺ (3, 4,∞).
Let β = (3, 4,∞). We find Mβ = {y
4, x3y2z2}.
So d{β, 1} = 0(X), d{β, 2} = 2(X) and d{β, 3} = 2(×).
Then V := {(4, 4, 2), (4, 2,∞), (1, 4,∞), (3, 3,∞)}.
2.4. Let T := V .
(iii) For α = (2, 1, 3) do:
2.1. V := φ.
2.2. V := {(4, 4, 2), (1, 4,∞)}.
2.3. α ≺ (4, 2,∞), and α ≺ (3, 3,∞).
• Let β = (4, 2,∞). We find Mβ = {x
4, x3y2z2}.
So d{β, 1} = 3(×), d{β, 2} = 0(X) and d{β, 3} = 2(X).
Then V := {(4, 4, 2), (1, 4,∞), (4, 1,∞), (4, 2, 3)}.
• Let β = (3, 3,∞). Then Mβ = {x
3y2z2, xy3z2}.
d{β, 1} = 1(X), d{β, 2} = 2(×), d{β, 3} = 2(X).
So V := {(4, 4, 2), (1, 4,∞), (4, 1,∞), (4, 2, 3), (2, 3,∞), (3, 3, 3)}.
2.4. Let T := V .
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Step 3. Output T= {(4, 4, 2), (1, 4,∞), (4, 1,∞), (4, 2, 3), (2, 3,∞), (3, 3, 3)}
= {(4, 4, 2), (4, 2, 3), (3, 3, 3), (4, 1,∞), (2, 3,∞), (1, 4,∞)}.
Some preprocess can be taken right before Step 2 to improve the efficiency of
the incremental algorithm. For each u ∈ {1, . . . , n}, we partition M into disjoint sub-
sets such that the monomials in each subset have the same degree in xu. We then store
these information, which requires memory complexity O(n · p). For each β ∈ T α2 , we
can find Mβ by only checking the monomials in the subset with degree bu in variable
xu for every u. Note that for generic monomial ideals each subset contains a unique
monomial. In this case Mβ contains n monomials, and it can be found by O(n) oper-
ations, instead of O(p) operations by scanning through the whole input monomial set.
B.7 Time Complexity and Conclusion
We estimate the running time of our algorithms by counting the number of
monomial operations (ie. comparisons and divisibility) used. Our recursive algorithm
depends heavily on the number of distinct degrees of each variable. Let sj be the
number of distinct degrees of xj where j = 1, . . . , n. Then the total number of
merge of subtrees used by the algorithm is at most
∏n
j=1 sj . Since each subtree has
at most p leaves(ie. p generators), each merge takes O(p2) monomial operations.
Hence the algorithm uses O(p2 ·
∏n
j=1 sj) monomial operations. This algorithm is
more efficient for highly non-generic monomial ideals. The benchmark analysis in
[20] compare several algorithms based on various slicing strategies, including our
recursive algorithm. It is shown there that our algorithm performs as a very close
second best one.
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The running time of our incremental algorithm is harder to estimate for general
ideals. For generic ideals, however, we can bound the time in terms of input and
output sizes. More precisely, suppose
I = 〈xc11 , . . . , x
cn
n , X
α1 , . . . , Xαp〉
is a generic monomial ideal in K[X] where Xαk ’s are sorted in lex order with variable
order x1 < . . . < xn. For 0 ≤ k ≤ p, let
I(k) = 〈x
c1
1 , . . . , x
cn
n , X
α1, . . . , Xαk〉.
All these ideals are generic. By Theorem 24, we have
1 = |Irr(I(0))| ≤ |Irr(I(1))| ≤ · · · ≤ |Irr(I(p))| = |Irr(I)|.
In an arbitrary stage of the incremental algorithm, we try to find the irreducible
components of I(k) from those of I(k−1). For each β ∈ Irr(I(k−1)), only those β in T
αk
2
(as defined in (33)) need to be updated. Note that I is generic, by the preprocess
Mβ can be found in O(n) operations. The numbers d(β, u, k), 1 ≤ u 6= k ≤ n, can
be computed by scanning through the monomials in Mβ once, thus using only O(n)
monomial operations. Then the numbers d(β, u), 1 ≤ u ≤ n, can be computed in
O(n2) operations. Hence for each β ∈ T αk2 , Step 2.3 uses at most O(n+ n
2) = O(n2)
monomial operations. Since T ⊃ T αk2 has at most ℓ elements where ℓ = |Irr(I)|,
Step 2.3 needs at most O(n2ℓ) monomial operations. Therefore, the total number of
monomial operations is at most O(n2pℓ). In fact, T αk2 is usually a small subset of T ,
the actual running time is much better than our worst-case estimate indicates.
We also want to point out that for generic monomial ideals, the incremental
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algorithm is an improved version of the recursive algorithm. Suppose we add the
new monomial Xαk into I(k−1). In Step 3.2 of the recursive algorithm, we need to
compute Irr(Tk). But in Step 2.3 of the incremental algorithm, only β ∈ T
αk
2 need
to be updated. We have the observation that T αk2 is a small subset of Irr(Tk) ⊗ cn.
By this observation we conclude the incremental algorithm is more efficient than the
recursive algorithm for generic monomial ideals. In non-generic case, the comparison
is not clear.
In all previous algorithms (including our recursive one) for monomial decom-
position, the storage in the intermediate stages may grow exponentially larger than
the output size. Our incremental algorithm seems to be the first algorithm for mono-
mial decomposition that the intermediate storage is bounded by the final output size.
Note that the output size ℓ can be exponentially large in n. In fact, it is proven in
[1] that ℓ = O(p[
n
2
]) for large p. Since the output size can be exponential in n, it is
impossible to have a polynomial time algorithm for monomial decomposition.
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